activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2147305	CHEMBL921990	Activity of human MARK1 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	106.0	CHEMBL5940	Homo sapiens	Activity	%	106.0
	2147305	CHEMBL921990	Activity of human MARK1 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	106.0	CHEMBL5940	Homo sapiens	Activity	%	106.0
	2248255	CHEMBL1012702	Inhibition of MARK1 at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	5.0	CHEMBL5940	Homo sapiens	INH	%	5.0
	2248256	CHEMBL1012702	Inhibition of MARK1 at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	-6.0	CHEMBL5940	Homo sapiens	INH	%	-6.0
	2356985	CHEMBL958281	Inhibition of MARK1 at 1 uM relative to control	B	Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525893	>	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	2470260	CHEMBL987179	Inhibition of MARK1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5940	Homo sapiens	INH	%	10.0
Not Evaluated	2476725	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL5940	Homo sapiens	Activity		
Not Evaluated	2478564	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL5940	Homo sapiens	Activity		
	2478767	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	15.5	CHEMBL5940	Homo sapiens	Activity	%	15.5
	2479550	CHEMBL988942	Binding affinity to human MARK1	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Kd	nM	207.0	CHEMBL5940	Homo sapiens	Kd	nM	207.0
	2479559	CHEMBL988942	Binding affinity to human MARK1	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Kd	nM	11000.0	CHEMBL5940	Homo sapiens	Kd	nM	11000.0
Not Evaluated	2479622	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL5940	Homo sapiens	Activity		
Not Evaluated	2479825	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL5940	Homo sapiens	Activity		
Active	2480622	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL5940	Homo sapiens	Activity		
	2480824	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	17.5	CHEMBL5940	Homo sapiens	Activity	%	17.5
	2486599	CHEMBL994966	Inhibition of MARK	B	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	>	Ki	nM	8440.0	CHEMBL5940	Homo sapiens	Ki	uM	8.44
	2567287	CHEMBL975474	Inhibition of human MARK1 kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	41.0	CHEMBL5940	Homo sapiens	Activity	%	41.0
Not Evaluated	2577243	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL5940	Homo sapiens	Activity		
Not Evaluated	2577446	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL5940	Homo sapiens	Activity		
Not Evaluated	2593651	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL5940	Homo sapiens	Activity		
	2593917	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	31.3	CHEMBL5940	Homo sapiens	Activity	%	31.3
Not Evaluated	2594120	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL5940	Homo sapiens	Activity		
Not Evaluated	2594860	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL5940	Homo sapiens	Activity		
Not Evaluated	2595063	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL5940	Homo sapiens	Activity		
Not Evaluated	2596260	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL5940	Homo sapiens	Activity		
Not Evaluated	2596463	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL5940	Homo sapiens	Activity		
Not Evaluated	2597732	CHEMBL982753	Binding affinity to human MARK1 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL5940	Homo sapiens	Activity		
	2721647	CHEMBL1057476	Inhibition of MARK1 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	2900380	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900381	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900382	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900383	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900384	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900385	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900386	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	2300.0	CHEMBL5940	Homo sapiens	Kd	nM	2300.0
	2900387	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900388	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900389	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900390	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900391	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900392	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	4000.0	CHEMBL5940	Homo sapiens	Kd	nM	4000.0
	2900393	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900394	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900395	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900396	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900397	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900398	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900399	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	620.0	CHEMBL5940	Homo sapiens	Kd	nM	620.0
	2900400	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900401	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900402	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900403	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900404	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900405	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	170.0	CHEMBL5940	Homo sapiens	Kd	nM	170.0
	2900406	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900407	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900408	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900409	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900410	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900411	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900412	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	4.0	CHEMBL5940	Homo sapiens	Kd	nM	4.0
	2900413	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1500.0	CHEMBL5940	Homo sapiens	Kd	nM	1500.0
	2900414	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1200.0	CHEMBL5940	Homo sapiens	Kd	nM	1200.0
	2900415	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	4900.0	CHEMBL5940	Homo sapiens	Kd	nM	4900.0
	2900416	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2900417	CHEMBL1061905	Binding constant for MARK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	2921277	CHEMBL1049122	Inhibition of MARK1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	97.0	CHEMBL5940	Homo sapiens	Activity	%	97.0
	2938485	CHEMBL1041380	Inhibition of MARK1 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	12.0	CHEMBL5940	Homo sapiens	INH	%	12.0
Not Active	2938585	CHEMBL1040598	Inhibition of MARK1 at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
	3052652	CHEMBL1041139	Residual activity of MARK1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	90.0	CHEMBL5940	Homo sapiens	Residual activity	%	90.0
	3053961	CHEMBL1050292	Residual activity of MARK1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	112.0	CHEMBL5940	Homo sapiens	Residual activity	%	112.0
	3054213	CHEMBL1040681	Residual activity of MARK1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	98.0	CHEMBL5940	Homo sapiens	Residual activity	%	98.0
	3055500	CHEMBL1041139	Residual activity of MARK1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	86.0	CHEMBL5940	Homo sapiens	Residual activity	%	86.0
	3056805	CHEMBL1050292	Residual activity of MARK1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	124.0	CHEMBL5940	Homo sapiens	Residual activity	%	124.0
	3057057	CHEMBL1040681	Residual activity of MARK1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	90.0	CHEMBL5940	Homo sapiens	Residual activity	%	90.0
	3058377	CHEMBL1041139	Residual activity of MARK1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	86.0	CHEMBL5940	Homo sapiens	Residual activity	%	86.0
	3058629	CHEMBL1050292	Residual activity of MARK1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	112.0	CHEMBL5940	Homo sapiens	Residual activity	%	112.0
	3072975	CHEMBL1040681	Residual activity of MARK1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	91.0	CHEMBL5940	Homo sapiens	Residual activity	%	91.0
	3213960	CHEMBL1116708	Inhibition of MARK1 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	3.0	CHEMBL5940	Homo sapiens	INH	%	3.0
	3224881	CHEMBL1100959	Inhibition of MARK1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	3226260	CHEMBL1100959	Inhibition of MARK1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
Not Active	3272048	CHEMBL1108306	Inhibition of MARK1	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
Not Active	3272369	CHEMBL1108306	Inhibition of MARK1	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
Not Active	3272370	CHEMBL1108306	Inhibition of MARK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
Not Active	3272371	CHEMBL1108306	Inhibition of MARK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
Not Active	3272372	CHEMBL1108306	Inhibition of MARK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
Not Active	3272373	CHEMBL1108306	Inhibition of MARK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
Not Active	3272374	CHEMBL1108306	Inhibition of MARK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
Not Active	3272375	CHEMBL1108306	Inhibition of MARK1	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
Not Active	3272376	CHEMBL1108306	Inhibition of MARK1	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
Not Active	3272377	CHEMBL1108306	Inhibition of MARK1	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
	3272378	CHEMBL1108306	Inhibition of MARK1	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL5940	Homo sapiens	INH	%	20.0
Not Active	3272379	CHEMBL1108306	Inhibition of MARK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
	3316792	CHEMBL1120351	Inhibition of MARK1 at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	-9.0	CHEMBL5940	Homo sapiens	INH	%	-9.0
	3332016	CHEMBL1166066	Inhibition of MARK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	3333431	CHEMBL1166066	Inhibition of MARK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	3334836	CHEMBL1166066	Inhibition of MARK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	3336256	CHEMBL1166066	Inhibition of MARK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	3337576	CHEMBL1166066	Inhibition of MARK1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	3338907	CHEMBL1166066	Inhibition of MARK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	3339160	CHEMBL1166066	Inhibition of MARK1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	3340464	CHEMBL1166066	Inhibition of MARK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	3341798	CHEMBL1166066	Inhibition of MARK1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	3343245	CHEMBL1166066	Inhibition of MARK1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	3358657	CHEMBL1174899	Inhibition of MARK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	83.0	CHEMBL5940	Homo sapiens	INH	%	83.0
	3359099	CHEMBL1174899	Inhibition of MARK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	100.0	CHEMBL5940	Homo sapiens	INH	%	100.0
	3409019	CHEMBL1219846	Inhibition of MARK1 ( assessed as residual activity at 1 uM )	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	Activity	%	28.0	CHEMBL5940	Homo sapiens	Activity	%	28.0
	3409032	CHEMBL1219846	Inhibition of MARK1 ( assessed as residual activity at 1 uM )	B	CC(C)NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214857	=	Activity	%	80.0	CHEMBL5940	Homo sapiens	Activity	%	80.0
	3409178	CHEMBL1219887	Inhibition of human MARK1	B	NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1214999	=	Inhibition	%	24.0	CHEMBL5940	Homo sapiens	INH	%	24.0
	3409188	CHEMBL1219887	Inhibition of human MARK1	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	Inhibition	%	82.0	CHEMBL5940	Homo sapiens	INH	%	82.0
	3443450	CHEMBL1244216	Inhibition of MARK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	8.0	CHEMBL5940	Homo sapiens	INH	%	8.0
	3443667	CHEMBL1244216	Inhibition of MARK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	24.0	CHEMBL5940	Homo sapiens	INH	%	24.0
	3444822	CHEMBL1244216	Inhibition of MARK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	2.0	CHEMBL5940	Homo sapiens	INH	%	2.0
	3445188	CHEMBL1244500	Binding affinity to MARK1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	83.0	CHEMBL5940	Homo sapiens	Kd	nM	83.0
	3445446	CHEMBL1244216	Inhibition of MARK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	1.0	CHEMBL5940	Homo sapiens	INH	%	1.0
	3445663	CHEMBL1244216	Inhibition of MARK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	15.0	CHEMBL5940	Homo sapiens	INH	%	15.0
	3448492	CHEMBL1244500	Binding affinity to MARK1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	3448980	CHEMBL1244500	Binding affinity to MARK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	170.0	CHEMBL5940	Homo sapiens	Kd	nM	170.0
	3449457	CHEMBL1244500	Binding affinity to MARK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1200.0	CHEMBL5940	Homo sapiens	Kd	nM	1200.0
	3449725	CHEMBL1244500	Binding affinity to MARK1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	3450129	CHEMBL1244500	Binding affinity to MARK1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	uM	10.0
	3451048	CHEMBL1244500	Binding affinity to MARK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	4900.0	CHEMBL5940	Homo sapiens	Kd	nM	4900.0
	3463284	CHEMBL1252487	Inhibition of MARK1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	65.0	CHEMBL5940	Homo sapiens	INH	%	65.0
	3463828	CHEMBL1252487	Inhibition of MARK1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	23.0	CHEMBL5940	Homo sapiens	INH	%	23.0
	3464047	CHEMBL1252487	Inhibition of MARK1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	95.0	CHEMBL5940	Homo sapiens	INH	%	95.0
Active	3564123	CHEMBL1285293	Inhibition of MARK1 at 0.1 uM	B	NC(=O)c1cccc(CNC(=O)c2cc3c(c4c2[nH]c2ccccc24)C(=O)NC3=O)c1		CHEMBL1278026		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
	5120822	CHEMBL1646806	Inhibition of MARK1 at 10 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	20.0	CHEMBL5940	Homo sapiens	INH	%	20.0
	5121135	CHEMBL1646192	Inhibition of human MARK1 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	113.0	CHEMBL5940	Homo sapiens	INH	%	113.0
	5140524	CHEMBL1646070	Inhibition of MARK1 at 1 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	20.0	CHEMBL5940	Homo sapiens	INH	%	20.0
	5235553	CHEMBL1686354	Inhibition of human MARK1 at 1 uM	B	C[C@H](C#N)NC(=O)c1cccc(-c2cc(-c3ccc(CNC4CCOCC4)cc3)on2)c1		CHEMBL1683440	=	Inhibition	%	29.0	CHEMBL5940	Homo sapiens	INH	%	29.0
	5243734	CHEMBL1685697	Inhibition of MARK1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	53.0	CHEMBL5940	Homo sapiens	INH	%	53.0
	5243842	CHEMBL1686054	Inhibition of MARK1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	21.0	CHEMBL5940	Homo sapiens	INH	%	21.0
	5243955	CHEMBL1685697	Inhibition of MARK1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	5.0	CHEMBL5940	Homo sapiens	INH	%	5.0
	5244063	CHEMBL1686054	Inhibition of MARK1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	0.0	CHEMBL5940	Homo sapiens	INH	%	0.0
	5244936	CHEMBL1685697	Inhibition of MARK1 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	94.0	CHEMBL5940	Homo sapiens	INH	%	94.0
	5245044	CHEMBL1686054	Inhibition of MARK1 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	51.0	CHEMBL5940	Homo sapiens	INH	%	51.0
	5245195	CHEMBL1685697	Inhibition of MARK1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	95.0	CHEMBL5940	Homo sapiens	INH	%	95.0
	5246025	CHEMBL1686054	Inhibition of MARK1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	64.0	CHEMBL5940	Homo sapiens	INH	%	64.0
	6340956	CHEMBL1827280	Activity of MARK1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	94.0	CHEMBL5940	Homo sapiens	Activity	%	94.0
	6352232	CHEMBL1825839	Inhibition of MARK1 assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	72.0	CHEMBL5940	Homo sapiens	Activity	%	72.0
	6375112	CHEMBL1838162	Inhibition of MARK1 at 1 uM	B	O=C(O)COc1ncnc2cc(-c3ccc4[nH]ncc4c3)sc12		CHEMBL1836641	=	Inhibition	%	1.3	CHEMBL5940	Homo sapiens	INH	%	1.3
	6375141	CHEMBL1838162	Inhibition of MARK1 at 1 uM	B	CC(=O)Nc1ccc(-c2cc3ncnc(SCC(=O)O)c3s2)cc1		CHEMBL1836724	=	Inhibition	%	23.0	CHEMBL5940	Homo sapiens	INH	%	23.0
	7567531	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7568002	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7568470	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7568902	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1500.0	CHEMBL5940	Homo sapiens	Kd	nM	1500.0
	7569045	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7569505	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7569977	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7570440	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7570867	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1200.0	CHEMBL5940	Homo sapiens	Kd	nM	1200.0
	7571021	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7571478	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7571954	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7572417	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7572833	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	31.0	CHEMBL5940	Homo sapiens	Kd	nM	31.0
	7573002	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7573459	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7573935	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	4200.0	CHEMBL5940	Homo sapiens	Kd	nM	4200.0
	7574980	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	1400.0	CHEMBL5940	Homo sapiens	Kd	nM	1400.0
	7575441	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7575935	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	170.0	CHEMBL5940	Homo sapiens	Kd	nM	170.0
	7576343	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7576954	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7577413	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7577449	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7577919	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7578324	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	700.0	CHEMBL5940	Homo sapiens	Kd	nM	700.0
	7578962	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7579336	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7579818	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	310.0	CHEMBL5940	Homo sapiens	Kd	nM	310.0
	7580287	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7580690	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7581708	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7582179	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7582643	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7583043	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	4900.0	CHEMBL5940	Homo sapiens	Kd	nM	4900.0
	7583224	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7583621	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7584066	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7584537	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7584999	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	270.0	CHEMBL5940	Homo sapiens	Kd	nM	270.0
	7585403	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7585554	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7585962	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7586408	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7586879	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7587333	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7587515	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7587934	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7588387	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7588858	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7589309	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7589480	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7589904	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	83.0	CHEMBL5940	Homo sapiens	Kd	nM	83.0
	7590371	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7590845	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7591453	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7591875	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	2300.0	CHEMBL5940	Homo sapiens	Kd	nM	2300.0
	7592347	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7592831	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7593420	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7593855	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7594358	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7594810	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7595388	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7595832	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7595864	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7596335	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7596782	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7597360	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7597844	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7598314	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5940	Homo sapiens	Kd	nM	10000.0
	7598756	CHEMBL1908810	Binding constant for MARK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	4.0	CHEMBL5940	Homo sapiens	Kd	nM	4.0
	7931113	CHEMBL1919450	Inhibition of MARK1 relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	8.0	CHEMBL5940	Homo sapiens	INH	%	8.0
	7961055	CHEMBL1932890	Inhibition of MARK1	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL5940	Homo sapiens	IC50	uM	30.0
	7961056	CHEMBL1932890	Inhibition of MARK1	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL5940	Homo sapiens	IC50	uM	30.0
	7969745	CHEMBL1931444	Inhibition of MARK1 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	86.0	CHEMBL5940	Homo sapiens	Activity	%	86.0
	7970438	CHEMBL1930179	Inhibition of MARK1 at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	0.0	CHEMBL5940	Homo sapiens	INH	%	0.0
	8002068	CHEMBL1942172	Inhibition of MARK1 at 1 uM	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	Inhibition	%	84.0	CHEMBL5940	Homo sapiens	INH	%	84.0
	8002069	CHEMBL1942172	Inhibition of MARK1 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	Inhibition	%	74.0	CHEMBL5940	Homo sapiens	INH	%	74.0
	8002070	CHEMBL1942172	Inhibition of MARK1 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	Inhibition	%	47.0	CHEMBL5940	Homo sapiens	INH	%	47.0
	8002738	CHEMBL1942297	Inhibition of MARK1	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	IC50	nM	110.0	CHEMBL5940	Homo sapiens	IC50	nM	110.0
	8002739	CHEMBL1942297	Inhibition of MARK1	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	IC50	nM	590.0	CHEMBL5940	Homo sapiens	IC50	nM	590.0
	8002740	CHEMBL1942297	Inhibition of MARK1	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	IC50	nM	1300.0	CHEMBL5940	Homo sapiens	IC50	nM	1300.0
	8061267	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.03	CHEMBL5940	Homo sapiens	Inhibition	%	2.03
	8061444	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.36	CHEMBL5940	Homo sapiens	Inhibition	%	1.36
	8061775	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.86	CHEMBL5940	Homo sapiens	Inhibition	%	4.86
	8061966	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.55	CHEMBL5940	Homo sapiens	Inhibition	%	3.55
	8062190	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	9.52	CHEMBL5940	Homo sapiens	Inhibition	%	9.52
	8062306	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.2	CHEMBL5940	Homo sapiens	Inhibition	%	3.2
	8062692	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	5.86	CHEMBL5940	Homo sapiens	Inhibition	%	5.86
	8062790	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.05	CHEMBL5940	Homo sapiens	Inhibition	%	-0.05
	8063014	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.76	CHEMBL5940	Homo sapiens	Inhibition	%	0.76
	8063146	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.6	CHEMBL5940	Homo sapiens	Inhibition	%	2.6
	8063313	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.21	CHEMBL5940	Homo sapiens	Inhibition	%	2.21
	8063537	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.97	CHEMBL5940	Homo sapiens	Inhibition	%	2.97
	8063645	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.86	CHEMBL5940	Homo sapiens	Inhibition	%	1.86
	8064051	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.64	CHEMBL5940	Homo sapiens	Inhibition	%	2.64
	8064166	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	7.22	CHEMBL5940	Homo sapiens	Inhibition	%	7.22
	8064390	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.53	CHEMBL5940	Homo sapiens	Inhibition	%	2.53
	8064600	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.76	CHEMBL5940	Homo sapiens	Inhibition	%	0.76
	8064738	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.68	CHEMBL5940	Homo sapiens	Inhibition	%	2.68
	8065128	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.93	CHEMBL5940	Homo sapiens	Inhibition	%	1.93
	8065244	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.27	CHEMBL5940	Homo sapiens	Inhibition	%	3.27
	8065468	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.41	CHEMBL5940	Homo sapiens	Inhibition	%	1.41
	8065643	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.63	CHEMBL5940	Homo sapiens	Inhibition	%	3.63
	8065982	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	10.83	CHEMBL5940	Homo sapiens	Inhibition	%	10.83
	8066192	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.68	CHEMBL5940	Homo sapiens	Inhibition	%	1.68
	8066328	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	20.43	CHEMBL5940	Homo sapiens	Inhibition	%	20.43
	8066552	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	4.67	CHEMBL5940	Homo sapiens	Inhibition	%	4.67
	8066718	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	5.02	CHEMBL5940	Homo sapiens	Inhibition	%	5.02
	8067066	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.86	CHEMBL5940	Homo sapiens	Inhibition	%	1.86
	8067241	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.26	CHEMBL5940	Homo sapiens	Inhibition	%	2.26
	8067586	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.76	CHEMBL5940	Homo sapiens	Inhibition	%	1.76
	8067796	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.49	CHEMBL5940	Homo sapiens	Inhibition	%	1.49
	8068155	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	32.31	CHEMBL5940	Homo sapiens	Inhibition	%	32.31
	8068319	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.98	CHEMBL5940	Homo sapiens	Inhibition	%	1.98
	8068668	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.17	CHEMBL5940	Homo sapiens	Inhibition	%	1.17
	8068842	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.1	CHEMBL5940	Homo sapiens	Inhibition	%	2.1
	8069191	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.2	CHEMBL5940	Homo sapiens	Inhibition	%	2.2
	8069486	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	4.43	CHEMBL5940	Homo sapiens	Inhibition	%	4.43
	8069647	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	5.43	CHEMBL5940	Homo sapiens	Inhibition	%	5.43
	8069871	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.46	CHEMBL5940	Homo sapiens	Inhibition	%	2.46
	8069997	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.93	CHEMBL5940	Homo sapiens	Inhibition	%	0.93
	8070169	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.1	CHEMBL5940	Homo sapiens	Inhibition	%	3.1
	8070393	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.73	CHEMBL5940	Homo sapiens	Inhibition	%	3.73
	8070518	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.23	CHEMBL5940	Homo sapiens	Inhibition	%	1.23
	8070816	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	35.38	CHEMBL5940	Homo sapiens	Inhibition	%	35.38
	8071197	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.87	CHEMBL5940	Homo sapiens	Inhibition	%	4.87
	8071323	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.0	CHEMBL5940	Homo sapiens	Inhibition	%	1.0
	8071547	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.95	CHEMBL5940	Homo sapiens	Inhibition	%	1.95
	8071720	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.45	CHEMBL5940	Homo sapiens	Inhibition	%	2.45
	8071845	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.49	CHEMBL5940	Homo sapiens	Inhibition	%	1.49
	8072069	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.76	CHEMBL5940	Homo sapiens	Inhibition	%	0.76
	8072159	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.21	CHEMBL5940	Homo sapiens	Inhibition	%	1.21
	8072383	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.49	CHEMBL5940	Homo sapiens	Inhibition	%	1.49
	8072540	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.28	CHEMBL5940	Homo sapiens	Inhibition	%	2.28
	8072889	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.44	CHEMBL5940	Homo sapiens	Inhibition	%	0.44
	8073056	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.7	CHEMBL5940	Homo sapiens	Inhibition	%	2.7
	8073405	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.29	CHEMBL5940	Homo sapiens	Inhibition	%	0.29
	8073524	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.5	CHEMBL5940	Homo sapiens	Inhibition	%	0.5
	8073748	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	3.86	CHEMBL5940	Homo sapiens	Inhibition	%	3.86
	8073981	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	4.99	CHEMBL5940	Homo sapiens	Inhibition	%	4.99
	8074133	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	4.31	CHEMBL5940	Homo sapiens	Inhibition	%	4.31
	8074487	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.45	CHEMBL5940	Homo sapiens	Inhibition	%	1.45
	8074644	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.13	CHEMBL5940	Homo sapiens	Inhibition	%	2.13
	8074995	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.48	CHEMBL5940	Homo sapiens	Inhibition	%	0.48
	8075330	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.51	CHEMBL5940	Homo sapiens	Inhibition	%	0.51
	8075567	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	11.98	CHEMBL5940	Homo sapiens	Inhibition	%	11.98
	8075708	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.35	CHEMBL5940	Homo sapiens	Inhibition	%	2.35
	8075932	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.49	CHEMBL5940	Homo sapiens	Inhibition	%	3.49
	8076074	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.76	CHEMBL5940	Homo sapiens	Inhibition	%	0.76
	8076222	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	4.3	CHEMBL5940	Homo sapiens	Inhibition	%	4.3
	8076446	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.11	CHEMBL5940	Homo sapiens	Inhibition	%	3.11
	8076580	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.18	CHEMBL5940	Homo sapiens	Inhibition	%	2.18
	8076906	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.81	CHEMBL5940	Homo sapiens	Inhibition	%	0.81
	8077153	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	77.23	CHEMBL5940	Homo sapiens	Inhibition	%	77.23
	8077505	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.96	CHEMBL5940	Homo sapiens	Inhibition	%	1.96
	8077656	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	5.8	CHEMBL5940	Homo sapiens	Inhibition	%	5.8
	8078023	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.45	CHEMBL5940	Homo sapiens	Inhibition	%	3.45
	8078162	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.41	CHEMBL5940	Homo sapiens	Inhibition	%	0.41
	8078488	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.47	CHEMBL5940	Homo sapiens	Inhibition	%	0.47
	8078738	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	93.14	CHEMBL5940	Homo sapiens	Inhibition	%	93.14
	8079078	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.25	CHEMBL5940	Homo sapiens	Inhibition	%	4.25
	8079236	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.87	CHEMBL5940	Homo sapiens	Inhibition	%	0.87
	8079460	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	5.71	CHEMBL5940	Homo sapiens	Inhibition	%	5.71
	8079602	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.63	CHEMBL5940	Homo sapiens	Inhibition	%	1.63
	8079741	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	8.64	CHEMBL5940	Homo sapiens	Inhibition	%	8.64
	8079965	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	9.11	CHEMBL5940	Homo sapiens	Inhibition	%	9.11
	8080070	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.75	CHEMBL5940	Homo sapiens	Inhibition	%	1.75
	8080322	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	42.69	CHEMBL5940	Homo sapiens	Inhibition	%	42.69
	8080546	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	87.06	CHEMBL5940	Homo sapiens	Inhibition	%	87.06
	8080661	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.85	CHEMBL5940	Homo sapiens	Inhibition	%	1.85
	8081049	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.83	CHEMBL5940	Homo sapiens	Inhibition	%	-0.83
	8081184	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.55	CHEMBL5940	Homo sapiens	Inhibition	%	2.55
	8081552	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	50.14	CHEMBL5940	Homo sapiens	Inhibition	%	50.14
	8081655	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.1	CHEMBL5940	Homo sapiens	Inhibition	%	2.1
	8081879	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	15.6	CHEMBL5940	Homo sapiens	Inhibition	%	15.6
	8082131	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	2.89	CHEMBL5940	Homo sapiens	Inhibition	%	2.89
	8082244	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	3.7	CHEMBL5940	Homo sapiens	Inhibition	%	3.7
	8082641	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.5	CHEMBL5940	Homo sapiens	Inhibition	%	-0.5
	8082764	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.6	CHEMBL5940	Homo sapiens	Inhibition	%	2.6
	8082988	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.46	CHEMBL5940	Homo sapiens	Inhibition	%	1.46
	8083144	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.69	CHEMBL5940	Homo sapiens	Inhibition	%	5.69
	8083467	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.98	CHEMBL5940	Homo sapiens	Inhibition	%	0.98
	8083721	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	16.53	CHEMBL5940	Homo sapiens	Inhibition	%	16.53
	8083831	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.8	CHEMBL5940	Homo sapiens	Inhibition	%	1.8
	8084055	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	6.88	CHEMBL5940	Homo sapiens	Inhibition	%	6.88
	8084240	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	12.78	CHEMBL5940	Homo sapiens	Inhibition	%	12.78
	8084582	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.96	CHEMBL5940	Homo sapiens	Inhibition	%	2.96
	8084743	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	22.26	CHEMBL5940	Homo sapiens	Inhibition	%	22.26
	8085065	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.49	CHEMBL5940	Homo sapiens	Inhibition	%	3.49
	8085321	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.6	CHEMBL5940	Homo sapiens	Inhibition	%	-0.6
	8085653	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.99	CHEMBL5940	Homo sapiens	Inhibition	%	1.99
	8085842	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	52.94	CHEMBL5940	Homo sapiens	Inhibition	%	52.94
	8086181	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.22	CHEMBL5940	Homo sapiens	Inhibition	%	3.22
	8086343	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	3.54	CHEMBL5940	Homo sapiens	Inhibition	%	3.54
	8086567	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	8.58	CHEMBL5940	Homo sapiens	Inhibition	%	8.58
	8086666	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.76	CHEMBL5940	Homo sapiens	Inhibition	%	0.76
	8086877	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.05	CHEMBL5940	Homo sapiens	Inhibition	%	2.05
	8087101	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.47	CHEMBL5940	Homo sapiens	Inhibition	%	2.47
	8087259	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.75	CHEMBL5940	Homo sapiens	Inhibition	%	0.75
	8087597	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.73	CHEMBL5940	Homo sapiens	Inhibition	%	2.73
	8087735	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.17	CHEMBL5940	Homo sapiens	Inhibition	%	6.17
	8088101	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.48	CHEMBL5940	Homo sapiens	Inhibition	%	3.48
	8088249	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.39	CHEMBL5940	Homo sapiens	Inhibition	%	0.39
	8088473	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.47	CHEMBL5940	Homo sapiens	Inhibition	%	1.47
	8088601	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.26	CHEMBL5940	Homo sapiens	Inhibition	%	4.26
	8088918	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.52	CHEMBL5940	Homo sapiens	Inhibition	%	3.52
	8089046	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-1.22	CHEMBL5940	Homo sapiens	Inhibition	%	-1.22
	8089270	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	2.97	CHEMBL5940	Homo sapiens	Inhibition	%	2.97
	8089418	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.11	CHEMBL5940	Homo sapiens	Inhibition	%	2.11
	8089762	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.31	CHEMBL5940	Homo sapiens	Inhibition	%	0.31
	8089942	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.05	CHEMBL5940	Homo sapiens	Inhibition	%	-0.05
	8090331	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.35	CHEMBL5940	Homo sapiens	Inhibition	%	3.35
	8090498	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.92	CHEMBL5940	Homo sapiens	Inhibition	%	0.92
	8090861	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.28	CHEMBL5940	Homo sapiens	Inhibition	%	0.28
	8091066	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.03	CHEMBL5940	Homo sapiens	Inhibition	%	3.03
	8091427	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.76	CHEMBL5940	Homo sapiens	Inhibition	%	2.76
	8091582	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.92	CHEMBL5940	Homo sapiens	Inhibition	%	1.92
	8091922	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.68	CHEMBL5940	Homo sapiens	Inhibition	%	5.68
	8092059	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.45	CHEMBL5940	Homo sapiens	Inhibition	%	0.45
	8092283	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.99	CHEMBL5940	Homo sapiens	Inhibition	%	0.99
	8092434	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-0.03	CHEMBL5940	Homo sapiens	Inhibition	%	-0.03
	8092806	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.88	CHEMBL5940	Homo sapiens	Inhibition	%	0.88
	8092935	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	9.07	CHEMBL5940	Homo sapiens	Inhibition	%	9.07
	8093247	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.69	CHEMBL5940	Homo sapiens	Inhibition	%	0.69
	8093611	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.67	CHEMBL5940	Homo sapiens	Inhibition	%	0.67
	8093750	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	24.76	CHEMBL5940	Homo sapiens	Inhibition	%	24.76
	8094094	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.38	CHEMBL5940	Homo sapiens	Inhibition	%	0.38
	8094274	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.07	CHEMBL5940	Homo sapiens	Inhibition	%	1.07
	8094498	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.26	CHEMBL5940	Homo sapiens	Inhibition	%	1.26
	8094673	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	7.7	CHEMBL5940	Homo sapiens	Inhibition	%	7.7
	8094829	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.0	CHEMBL5940	Homo sapiens	Inhibition	%	3.0
	8095053	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.05	CHEMBL5940	Homo sapiens	Inhibition	%	2.05
	8095193	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.36	CHEMBL5940	Homo sapiens	Inhibition	%	2.36
	8095396	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.05	CHEMBL5940	Homo sapiens	Inhibition	%	2.05
	8095761	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	16.14	CHEMBL5940	Homo sapiens	Inhibition	%	16.14
	8095909	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.12	CHEMBL5940	Homo sapiens	Inhibition	%	1.12
	8096133	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.17	CHEMBL5940	Homo sapiens	Inhibition	%	3.17
	8096250	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.6	CHEMBL5940	Homo sapiens	Inhibition	%	3.6
	8096613	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.37	CHEMBL5940	Homo sapiens	Inhibition	%	1.37
	8096769	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.02	CHEMBL5940	Homo sapiens	Inhibition	%	3.02
	8097140	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.73	CHEMBL5940	Homo sapiens	Inhibition	%	2.73
	8097447	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.09	CHEMBL5940	Homo sapiens	Inhibition	%	3.09
	8097671	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	2.74	CHEMBL5940	Homo sapiens	Inhibition	%	2.74
	8097821	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	19.85	CHEMBL5940	Homo sapiens	Inhibition	%	19.85
	8097954	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.32	CHEMBL5940	Homo sapiens	Inhibition	%	0.32
	8098178	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	3.08	CHEMBL5940	Homo sapiens	Inhibition	%	3.08
	8098298	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.58	CHEMBL5940	Homo sapiens	Inhibition	%	0.58
	8098702	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.18	CHEMBL5940	Homo sapiens	Inhibition	%	0.18
	8098887	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	47.69	CHEMBL5940	Homo sapiens	Inhibition	%	47.69
	8099255	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.62	CHEMBL5940	Homo sapiens	Inhibition	%	1.62
	8099397	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	4.34	CHEMBL5940	Homo sapiens	Inhibition	%	4.34
	8099591	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.42	CHEMBL5940	Homo sapiens	Inhibition	%	0.42
	8099815	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.08	CHEMBL5940	Homo sapiens	Inhibition	%	1.08
	8099962	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.16	CHEMBL5940	Homo sapiens	Inhibition	%	3.16
	8100332	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.3	CHEMBL5940	Homo sapiens	Inhibition	%	2.3
	8100448	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.58	CHEMBL5940	Homo sapiens	Inhibition	%	3.58
	8100672	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.23	CHEMBL5940	Homo sapiens	Inhibition	%	0.23
	8100812	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.21	CHEMBL5940	Homo sapiens	Inhibition	%	2.21
	8100972	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.8	CHEMBL5940	Homo sapiens	Inhibition	%	2.8
	8101196	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.12	CHEMBL5940	Homo sapiens	Inhibition	%	4.12
	8101338	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	2.34	CHEMBL5940	Homo sapiens	Inhibition	%	2.34
	8101523	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.24	CHEMBL5940	Homo sapiens	Inhibition	%	3.24
	8101747	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.92	CHEMBL5940	Homo sapiens	Inhibition	%	2.92
	8102000	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	8.15	CHEMBL5940	Homo sapiens	Inhibition	%	8.15
	8102155	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.84	CHEMBL5940	Homo sapiens	Inhibition	%	-1.84
	8102510	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.44	CHEMBL5940	Homo sapiens	Inhibition	%	1.44
	8102630	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.16	CHEMBL5940	Homo sapiens	Inhibition	%	1.16
	8102854	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.74	CHEMBL5940	Homo sapiens	Inhibition	%	0.74
	8103032	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.8	CHEMBL5940	Homo sapiens	Inhibition	%	1.8
	8103228	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.28	CHEMBL5940	Homo sapiens	Inhibition	%	2.28
	8103590	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.81	CHEMBL5940	Homo sapiens	Inhibition	%	0.81
	8103740	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.61	CHEMBL5940	Homo sapiens	Inhibition	%	2.61
	8103964	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.03	CHEMBL5940	Homo sapiens	Inhibition	%	2.03
	8104149	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.33	CHEMBL5940	Homo sapiens	Inhibition	%	0.33
	8104297	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.21	CHEMBL5940	Homo sapiens	Inhibition	%	6.21
	8104521	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.83	CHEMBL5940	Homo sapiens	Inhibition	%	3.83
	8104667	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	15.64	CHEMBL5940	Homo sapiens	Inhibition	%	15.64
	8105005	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.06	CHEMBL5940	Homo sapiens	Inhibition	%	3.06
	8105145	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.08	CHEMBL5940	Homo sapiens	Inhibition	%	1.08
	8105535	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.46	CHEMBL5940	Homo sapiens	Inhibition	%	3.46
	8105673	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	15.58	CHEMBL5940	Homo sapiens	Inhibition	%	15.58
	8105897	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.26	CHEMBL5940	Homo sapiens	Inhibition	%	1.26
	8105953	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.42	CHEMBL5940	Homo sapiens	Inhibition	%	1.42
	8106342	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	3.37	CHEMBL5940	Homo sapiens	Inhibition	%	3.37
	8106498	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	11.66	CHEMBL5940	Homo sapiens	Inhibition	%	11.66
	8106722	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	4.42	CHEMBL5940	Homo sapiens	Inhibition	%	4.42
	8106851	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.58	CHEMBL5940	Homo sapiens	Inhibition	%	2.58
	8107196	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	3.68	CHEMBL5940	Homo sapiens	Inhibition	%	3.68
	8107368	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.79	CHEMBL5940	Homo sapiens	Inhibition	%	1.79
	8107569	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	27.34	CHEMBL5940	Homo sapiens	Inhibition	%	27.34
	8107793	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.41	CHEMBL5940	Homo sapiens	Inhibition	%	2.41
	8107928	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.94	CHEMBL5940	Homo sapiens	Inhibition	%	2.94
	8108310	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.3	CHEMBL5940	Homo sapiens	Inhibition	%	4.3
	8108485	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.88	CHEMBL5940	Homo sapiens	Inhibition	%	2.88
	8108856	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	24.33	CHEMBL5940	Homo sapiens	Inhibition	%	24.33
	8108998	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.2	CHEMBL5940	Homo sapiens	Inhibition	%	-0.2
	8109336	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.59	CHEMBL5940	Homo sapiens	Inhibition	%	3.59
	8109466	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.02	CHEMBL5940	Homo sapiens	Inhibition	%	2.02
	8109690	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.38	CHEMBL5940	Homo sapiens	Inhibition	%	1.38
	8109861	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	8.24	CHEMBL5940	Homo sapiens	Inhibition	%	8.24
	8110217	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.72	CHEMBL5940	Homo sapiens	Inhibition	%	4.72
	8110272	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.83	CHEMBL5940	Homo sapiens	Inhibition	%	0.83
	8110496	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.97	CHEMBL5940	Homo sapiens	Inhibition	%	1.97
	8110662	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.8	CHEMBL5940	Homo sapiens	Inhibition	%	1.8
	8111044	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	11.0	CHEMBL5940	Homo sapiens	Inhibition	%	11.0
	8111167	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.69	CHEMBL5940	Homo sapiens	Inhibition	%	1.69
	8111518	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	13.79	CHEMBL5940	Homo sapiens	Inhibition	%	13.79
	8111684	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.6	CHEMBL5940	Homo sapiens	Inhibition	%	1.6
	8111908	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	10.35	CHEMBL5940	Homo sapiens	Inhibition	%	10.35
	8112113	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	8.07	CHEMBL5940	Homo sapiens	Inhibition	%	8.07
	8112250	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.08	CHEMBL5940	Homo sapiens	Inhibition	%	0.08
	8112642	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.57	CHEMBL5940	Homo sapiens	Inhibition	%	3.57
	8112814	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.89	CHEMBL5940	Homo sapiens	Inhibition	%	-0.89
	8113190	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.55	CHEMBL5940	Homo sapiens	Inhibition	%	1.55
	8113326	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.87	CHEMBL5940	Homo sapiens	Inhibition	%	2.87
	8113550	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.39	CHEMBL5940	Homo sapiens	Inhibition	%	0.39
	8113674	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.89	CHEMBL5940	Homo sapiens	Inhibition	%	4.89
	8114014	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.03	CHEMBL5940	Homo sapiens	Inhibition	%	0.03
	8114190	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.99	CHEMBL5940	Homo sapiens	Inhibition	%	0.99
	8114546	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.72	CHEMBL5940	Homo sapiens	Inhibition	%	2.72
	8114822	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.65	CHEMBL5940	Homo sapiens	Inhibition	%	0.65
	8114988	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.91	CHEMBL5940	Homo sapiens	Inhibition	%	1.91
	8115377	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.05	CHEMBL5940	Homo sapiens	Inhibition	%	1.05
	8115497	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.31	CHEMBL5940	Homo sapiens	Inhibition	%	0.31
	8115721	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.43	CHEMBL5940	Homo sapiens	Inhibition	%	1.43
	8115854	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	61.09	CHEMBL5940	Homo sapiens	Inhibition	%	61.09
	8116237	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	52.47	CHEMBL5940	Homo sapiens	Inhibition	%	52.47
	8116440	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	20.84	CHEMBL5940	Homo sapiens	Inhibition	%	20.84
	8116574	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.32	CHEMBL5940	Homo sapiens	Inhibition	%	1.32
	8116798	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.84	CHEMBL5940	Homo sapiens	Inhibition	%	-0.84
	8116970	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	5.62	CHEMBL5940	Homo sapiens	Inhibition	%	5.62
	8117141	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.23	CHEMBL5940	Homo sapiens	Inhibition	%	1.23
	8117365	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	2.29	CHEMBL5940	Homo sapiens	Inhibition	%	2.29
	8117523	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	10.34	CHEMBL5940	Homo sapiens	Inhibition	%	10.34
	8117877	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.89	CHEMBL5940	Homo sapiens	Inhibition	%	1.89
	8118015	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.93	CHEMBL5940	Homo sapiens	Inhibition	%	2.93
	8118355	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.41	CHEMBL5940	Homo sapiens	Inhibition	%	0.41
	8118527	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.78	CHEMBL5940	Homo sapiens	Inhibition	%	3.78
	8118751	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.03	CHEMBL5940	Homo sapiens	Inhibition	%	2.03
	8118887	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.69	CHEMBL5940	Homo sapiens	Inhibition	%	5.69
	8119158	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.37	CHEMBL5940	Homo sapiens	Inhibition	%	-0.37
	8119317	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	3.01	CHEMBL5940	Homo sapiens	Inhibition	%	3.01
	8119541	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	2.3	CHEMBL5940	Homo sapiens	Inhibition	%	2.3
	8119708	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.12	CHEMBL5940	Homo sapiens	Inhibition	%	1.12
	8120051	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.33	CHEMBL5940	Homo sapiens	Inhibition	%	1.33
	8120190	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.39	CHEMBL5940	Homo sapiens	Inhibition	%	1.39
	8120574	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.33	CHEMBL5940	Homo sapiens	Inhibition	%	0.33
	8120775	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	74.1	CHEMBL5940	Homo sapiens	Inhibition	%	74.1
	8121127	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.9	CHEMBL5940	Homo sapiens	Inhibition	%	0.9
	8121299	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.63	CHEMBL5940	Homo sapiens	Inhibition	%	1.63
	8121690	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	5.9	CHEMBL5940	Homo sapiens	Inhibition	%	5.9
	8121853	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.32	CHEMBL5940	Homo sapiens	Inhibition	%	2.32
	8122198	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.63	CHEMBL5940	Homo sapiens	Inhibition	%	-0.63
	8122336	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	4.99	CHEMBL5940	Homo sapiens	Inhibition	%	4.99
	8122560	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	13.62	CHEMBL5940	Homo sapiens	Inhibition	%	13.62
	8122680	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.61	CHEMBL5940	Homo sapiens	Inhibition	%	1.61
	8123071	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.83	CHEMBL5940	Homo sapiens	Inhibition	%	4.83
	8123213	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	4.83	CHEMBL5940	Homo sapiens	Inhibition	%	4.83
	8123491	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.38	CHEMBL5940	Homo sapiens	Inhibition	%	1.38
	8123865	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	8.38	CHEMBL5940	Homo sapiens	Inhibition	%	8.38
	8124032	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	1.01	CHEMBL5940	Homo sapiens	Inhibition	%	1.01
	8124375	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.15	CHEMBL5940	Homo sapiens	Inhibition	%	4.15
	8124514	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.56	CHEMBL5940	Homo sapiens	Inhibition	%	2.56
	8124738	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.11	CHEMBL5940	Homo sapiens	Inhibition	%	1.11
	8124903	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	3.97	CHEMBL5940	Homo sapiens	Inhibition	%	3.97
	8125104	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.13	CHEMBL5940	Homo sapiens	Inhibition	%	3.13
	8125328	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	7.96	CHEMBL5940	Homo sapiens	Inhibition	%	7.96
	8125458	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.14	CHEMBL5940	Homo sapiens	Inhibition	%	-0.14
	8125626	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.56	CHEMBL5940	Homo sapiens	Inhibition	%	2.56
	8125850	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.58	CHEMBL5940	Homo sapiens	Inhibition	%	1.58
	8126014	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.92	CHEMBL5940	Homo sapiens	Inhibition	%	0.92
	8126178	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.92	CHEMBL5940	Homo sapiens	Inhibition	%	5.92
	8126402	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	4.03	CHEMBL5940	Homo sapiens	Inhibition	%	4.03
	8126517	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.26	CHEMBL5940	Homo sapiens	Inhibition	%	-0.26
	8126877	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	53.76	CHEMBL5940	Homo sapiens	Inhibition	%	53.76
	8126999	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.1	CHEMBL5940	Homo sapiens	Inhibition	%	2.1
	8127223	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.13	CHEMBL5940	Homo sapiens	Inhibition	%	4.13
	8127390	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	1.75	CHEMBL5940	Homo sapiens	Inhibition	%	1.75
	8127532	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	22.1	CHEMBL5940	Homo sapiens	Inhibition	%	22.1
	8127756	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.95	CHEMBL5940	Homo sapiens	Inhibition	%	3.95
	8127820	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.87	CHEMBL5940	Homo sapiens	Inhibition	%	1.87
	8128044	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	6.76	CHEMBL5940	Homo sapiens	Inhibition	%	6.76
	8128196	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.15	CHEMBL5940	Homo sapiens	Inhibition	%	1.15
	8128363	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	6.09	CHEMBL5940	Homo sapiens	Inhibition	%	6.09
	8128587	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.46	CHEMBL5940	Homo sapiens	Inhibition	%	1.46
	8128706	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	27.67	CHEMBL5940	Homo sapiens	Inhibition	%	27.67
	8129067	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	6.27	CHEMBL5940	Homo sapiens	Inhibition	%	6.27
	8129238	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-2.08	CHEMBL5940	Homo sapiens	Inhibition	%	-2.08
	8129651	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.73	CHEMBL5940	Homo sapiens	Inhibition	%	1.73
	8129790	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.29	CHEMBL5940	Homo sapiens	Inhibition	%	0.29
	8130175	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	4.46	CHEMBL5940	Homo sapiens	Inhibition	%	4.46
	8130347	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.69	CHEMBL5940	Homo sapiens	Inhibition	%	2.69
	8130731	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	20.88	CHEMBL5940	Homo sapiens	Inhibition	%	20.88
	8130847	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.44	CHEMBL5940	Homo sapiens	Inhibition	%	1.44
	8131210	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.28	CHEMBL5940	Homo sapiens	Inhibition	%	4.28
	8131554	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.42	CHEMBL5940	Homo sapiens	Inhibition	%	1.42
	8131721	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.44	CHEMBL5940	Homo sapiens	Inhibition	%	4.44
	8132086	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	8.44	CHEMBL5940	Homo sapiens	Inhibition	%	8.44
	8132372	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.72	CHEMBL5940	Homo sapiens	Inhibition	%	0.72
	8132519	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.29	CHEMBL5940	Homo sapiens	Inhibition	%	1.29
	8132911	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	5.24	CHEMBL5940	Homo sapiens	Inhibition	%	5.24
	8133032	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.55	CHEMBL5940	Homo sapiens	Inhibition	%	1.55
	8133256	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.16	CHEMBL5940	Homo sapiens	Inhibition	%	1.16
	8133394	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.89	CHEMBL5940	Homo sapiens	Inhibition	%	1.89
	8133566	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.81	CHEMBL5940	Homo sapiens	Inhibition	%	1.81
	8133790	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.09	CHEMBL5940	Homo sapiens	Inhibition	%	1.09
	8133970	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	15.21	CHEMBL5940	Homo sapiens	Inhibition	%	15.21
	8134118	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.03	CHEMBL5940	Homo sapiens	Inhibition	%	0.03
	8134342	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.81	CHEMBL5940	Homo sapiens	Inhibition	%	2.81
	8134502	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.5	CHEMBL5940	Homo sapiens	Inhibition	%	0.5
	8134686	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	3.85	CHEMBL5940	Homo sapiens	Inhibition	%	3.85
	8135070	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.24	CHEMBL5940	Homo sapiens	Inhibition	%	1.24
	8135185	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.65	CHEMBL5940	Homo sapiens	Inhibition	%	1.65
	8135409	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.72	CHEMBL5940	Homo sapiens	Inhibition	%	2.72
	8135550	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	8.07	CHEMBL5940	Homo sapiens	Inhibition	%	8.07
	8135895	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.49	CHEMBL5940	Homo sapiens	Inhibition	%	1.49
	8136063	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.69	CHEMBL5940	Homo sapiens	Inhibition	%	0.69
	8136287	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.26	CHEMBL5940	Homo sapiens	Inhibition	%	2.26
	8136431	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.98	CHEMBL5940	Homo sapiens	Inhibition	%	2.98
	8136721	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.97	CHEMBL5940	Homo sapiens	Inhibition	%	1.97
	8136856	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.33	CHEMBL5940	Homo sapiens	Inhibition	%	0.33
	8137080	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	5.92	CHEMBL5940	Homo sapiens	Inhibition	%	5.92
	8137243	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.01	CHEMBL5940	Homo sapiens	Inhibition	%	2.01
	8137587	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.88	CHEMBL5940	Homo sapiens	Inhibition	%	0.88
	8137735	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.48	CHEMBL5940	Homo sapiens	Inhibition	%	2.48
	8138125	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	2.84	CHEMBL5940	Homo sapiens	Inhibition	%	2.84
	8138304	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.0	CHEMBL5940	Homo sapiens	Inhibition	%	1.0
	8138676	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.27	CHEMBL5940	Homo sapiens	Inhibition	%	0.27
	8138834	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.39	CHEMBL5940	Homo sapiens	Inhibition	%	1.39
	8139019	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	23.82	CHEMBL5940	Homo sapiens	Inhibition	%	23.82
	8139243	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.84	CHEMBL5940	Homo sapiens	Inhibition	%	0.84
	8139402	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.82	CHEMBL5940	Homo sapiens	Inhibition	%	4.82
	8139740	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.11	CHEMBL5940	Homo sapiens	Inhibition	%	4.11
	8139881	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.1	CHEMBL5940	Homo sapiens	Inhibition	%	4.1
	8140105	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.65	CHEMBL5940	Homo sapiens	Inhibition	%	3.65
	8140228	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.28	CHEMBL5940	Homo sapiens	Inhibition	%	1.28
	8140611	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.14	CHEMBL5940	Homo sapiens	Inhibition	%	2.14
	8140754	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.01	CHEMBL5940	Homo sapiens	Inhibition	%	5.01
	8141056	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.84	CHEMBL5940	Homo sapiens	Inhibition	%	1.84
	8141410	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.31	CHEMBL5940	Homo sapiens	Inhibition	%	-0.31
	8141570	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	10.3	CHEMBL5940	Homo sapiens	Inhibition	%	10.3
	8141913	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.89	CHEMBL5940	Homo sapiens	Inhibition	%	0.89
	8142074	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.34	CHEMBL5940	Homo sapiens	Inhibition	%	0.34
	8142298	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	2.66	CHEMBL5940	Homo sapiens	Inhibition	%	2.66
	8142466	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	8.37	CHEMBL5940	Homo sapiens	Inhibition	%	8.37
	8142642	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.98	CHEMBL5940	Homo sapiens	Inhibition	%	1.98
	8143015	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.65	CHEMBL5940	Homo sapiens	Inhibition	%	0.65
	8143170	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.19	CHEMBL5940	Homo sapiens	Inhibition	%	2.19
	8143394	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.58	CHEMBL5940	Homo sapiens	Inhibition	%	3.58
	8143581	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.09	CHEMBL5940	Homo sapiens	Inhibition	%	2.09
	8143740	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.58	CHEMBL5940	Homo sapiens	Inhibition	%	1.58
	8144078	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.99	CHEMBL5940	Homo sapiens	Inhibition	%	1.99
	8144441	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.44	CHEMBL5940	Homo sapiens	Inhibition	%	1.44
	8144571	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.37	CHEMBL5940	Homo sapiens	Inhibition	%	3.37
	8144948	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.58	CHEMBL5940	Homo sapiens	Inhibition	%	3.58
	8145085	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.69	CHEMBL5940	Homo sapiens	Inhibition	%	3.69
	8145309	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.01	CHEMBL5940	Homo sapiens	Inhibition	%	5.01
	8145398	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.15	CHEMBL5940	Homo sapiens	Inhibition	%	3.15
	8145746	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.25	CHEMBL5940	Homo sapiens	Inhibition	%	0.25
	8145907	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.52	CHEMBL5940	Homo sapiens	Inhibition	%	3.52
	8146131	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	10.8	CHEMBL5940	Homo sapiens	Inhibition	%	10.8
	8146251	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.73	CHEMBL5940	Homo sapiens	Inhibition	%	1.73
	8146635	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.48	CHEMBL5940	Homo sapiens	Inhibition	%	2.48
	8146802	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	50.67	CHEMBL5940	Homo sapiens	Inhibition	%	50.67
	8146971	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-0.23	CHEMBL5940	Homo sapiens	Inhibition	%	-0.23
	8147195	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.5	CHEMBL5940	Homo sapiens	Inhibition	%	1.5
	8147337	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.35	CHEMBL5940	Homo sapiens	Inhibition	%	2.35
	8147714	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.45	CHEMBL5940	Homo sapiens	Inhibition	%	1.45
	8147901	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.62	CHEMBL5940	Homo sapiens	Inhibition	%	1.62
	8148059	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	4.76	CHEMBL5940	Homo sapiens	Inhibition	%	4.76
	8148283	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	1.31	CHEMBL5940	Homo sapiens	Inhibition	%	1.31
	8148397	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.61	CHEMBL5940	Homo sapiens	Inhibition	%	1.61
	8148760	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	5.2	CHEMBL5940	Homo sapiens	Inhibition	%	5.2
	8148898	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.78	CHEMBL5940	Homo sapiens	Inhibition	%	2.78
	8149122	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.16	CHEMBL5940	Homo sapiens	Inhibition	%	4.16
	8149281	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.76	CHEMBL5940	Homo sapiens	Inhibition	%	0.76
	8149639	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.84	CHEMBL5940	Homo sapiens	Inhibition	%	1.84
	8149737	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.32	CHEMBL5940	Homo sapiens	Inhibition	%	1.32
	8149961	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.49	CHEMBL5940	Homo sapiens	Inhibition	%	0.49
	8150086	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-1.16	CHEMBL5940	Homo sapiens	Inhibition	%	-1.16
	8150470	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.72	CHEMBL5940	Homo sapiens	Inhibition	%	-0.72
	8150590	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	2.38	CHEMBL5940	Homo sapiens	Inhibition	%	2.38
	8150979	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	5.99	CHEMBL5940	Homo sapiens	Inhibition	%	5.99
	8151142	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.44	CHEMBL5940	Homo sapiens	Inhibition	%	0.44
	8151543	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.89	CHEMBL5940	Homo sapiens	Inhibition	%	0.89
	8151681	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.53	CHEMBL5940	Homo sapiens	Inhibition	%	2.53
	8152059	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.55	CHEMBL5940	Homo sapiens	Inhibition	%	3.55
	8152247	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.65	CHEMBL5940	Homo sapiens	Inhibition	%	5.65
	8152629	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.58	CHEMBL5940	Homo sapiens	Inhibition	%	4.58
	8152743	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.93	CHEMBL5940	Homo sapiens	Inhibition	%	2.93
	8152967	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.99	CHEMBL5940	Homo sapiens	Inhibition	%	3.99
	8153106	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.62	CHEMBL5940	Homo sapiens	Inhibition	%	2.62
	8153467	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.63	CHEMBL5940	Homo sapiens	Inhibition	%	2.63
	8153624	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.29	CHEMBL5940	Homo sapiens	Inhibition	%	-0.29
	8153981	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	14.92	CHEMBL5940	Homo sapiens	Inhibition	%	14.92
	8154302	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.03	CHEMBL5940	Homo sapiens	Inhibition	%	2.03
	8154428	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.35	CHEMBL5940	Homo sapiens	Inhibition	%	0.35
	8154811	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.6	CHEMBL5940	Homo sapiens	Inhibition	%	1.6
	8154931	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.55	CHEMBL5940	Homo sapiens	Inhibition	%	0.55
	8155155	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.21	CHEMBL5940	Homo sapiens	Inhibition	%	-0.21
	8155331	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.24	CHEMBL5940	Homo sapiens	Inhibition	%	-0.24
	8155492	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	2.83	CHEMBL5940	Homo sapiens	Inhibition	%	2.83
	8155716	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.44	CHEMBL5940	Homo sapiens	Inhibition	%	1.44
	8155894	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.47	CHEMBL5940	Homo sapiens	Inhibition	%	2.47
	8156032	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.43	CHEMBL5940	Homo sapiens	Inhibition	%	2.43
	8156256	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.98	CHEMBL5940	Homo sapiens	Inhibition	%	3.98
	8156468	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.62	CHEMBL5940	Homo sapiens	Inhibition	%	5.62
	8156618	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.04	CHEMBL5940	Homo sapiens	Inhibition	%	3.04
	8156842	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.9	CHEMBL5940	Homo sapiens	Inhibition	%	2.9
	8156985	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	12.93	CHEMBL5940	Homo sapiens	Inhibition	%	12.93
	8157329	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.89	CHEMBL5940	Homo sapiens	Inhibition	%	3.89
	8157470	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.7	CHEMBL5940	Homo sapiens	Inhibition	%	2.7
	8157824	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.1	CHEMBL5940	Homo sapiens	Inhibition	%	3.1
	8157985	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.09	CHEMBL5940	Homo sapiens	Inhibition	%	0.09
	8158209	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.78	CHEMBL5940	Homo sapiens	Inhibition	%	0.78
	8158235	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.84	CHEMBL5940	Homo sapiens	Inhibition	%	4.84
	8158459	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.67	CHEMBL5940	Homo sapiens	Inhibition	%	4.67
	8158617	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	8.31	CHEMBL5940	Homo sapiens	Inhibition	%	8.31
	8158786	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.47	CHEMBL5940	Homo sapiens	Inhibition	%	2.47
	8159010	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	5.89	CHEMBL5940	Homo sapiens	Inhibition	%	5.89
	8159145	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.71	CHEMBL5940	Homo sapiens	Inhibition	%	6.71
	8159489	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.07	CHEMBL5940	Homo sapiens	Inhibition	%	2.07
	8159620	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	11.46	CHEMBL5940	Homo sapiens	Inhibition	%	11.46
	8159844	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	10.97	CHEMBL5940	Homo sapiens	Inhibition	%	10.97
	8159985	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.07	CHEMBL5940	Homo sapiens	Inhibition	%	4.07
	8160346	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.04	CHEMBL5940	Homo sapiens	Inhibition	%	6.04
	8160496	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.13	CHEMBL5940	Homo sapiens	Inhibition	%	-0.13
	8160790	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.21	CHEMBL5940	Homo sapiens	Inhibition	%	5.21
	8161164	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	7.21	CHEMBL5940	Homo sapiens	Inhibition	%	7.21
	8161307	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	4.18	CHEMBL5940	Homo sapiens	Inhibition	%	4.18
	8161656	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.97	CHEMBL5940	Homo sapiens	Inhibition	%	1.97
	8161794	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	15.54	CHEMBL5940	Homo sapiens	Inhibition	%	15.54
	8162018	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.98	CHEMBL5940	Homo sapiens	Inhibition	%	3.98
	8162148	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	15.16	CHEMBL5940	Homo sapiens	Inhibition	%	15.16
	8162532	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.66	CHEMBL5940	Homo sapiens	Inhibition	%	0.66
	8162785	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	12.79	CHEMBL5940	Homo sapiens	Inhibition	%	12.79
	8162933	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	30.75	CHEMBL5940	Homo sapiens	Inhibition	%	30.75
	8163326	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.26	CHEMBL5940	Homo sapiens	Inhibition	%	3.26
	8163460	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.07	CHEMBL5940	Homo sapiens	Inhibition	%	5.07
	8163684	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	14.85	CHEMBL5940	Homo sapiens	Inhibition	%	14.85
	8163807	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.24	CHEMBL5940	Homo sapiens	Inhibition	%	3.24
	8164165	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	52.91	CHEMBL5940	Homo sapiens	Inhibition	%	52.91
	8164305	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.88	CHEMBL5940	Homo sapiens	Inhibition	%	1.88
	8164684	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	6.5	CHEMBL5940	Homo sapiens	Inhibition	%	6.5
	8164828	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.51	CHEMBL5940	Homo sapiens	Inhibition	%	0.51
	8165052	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.32	CHEMBL5940	Homo sapiens	Inhibition	%	2.32
	8165122	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.87	CHEMBL5940	Homo sapiens	Inhibition	%	4.87
	8165487	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.18	CHEMBL5940	Homo sapiens	Inhibition	%	2.18
	8165630	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	24.28	CHEMBL5940	Homo sapiens	Inhibition	%	24.28
	8165854	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.83	CHEMBL5940	Homo sapiens	Inhibition	%	0.83
	8165980	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	8.19	CHEMBL5940	Homo sapiens	Inhibition	%	8.19
	8166342	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	17.48	CHEMBL5940	Homo sapiens	Inhibition	%	17.48
	8166472	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.58	CHEMBL5940	Homo sapiens	Inhibition	%	1.58
	8166797	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	8.82	CHEMBL5940	Homo sapiens	Inhibition	%	8.82
	8167109	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.31	CHEMBL5940	Homo sapiens	Inhibition	%	3.31
	8167250	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	67.27	CHEMBL5940	Homo sapiens	Inhibition	%	67.27
	8167474	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	6.98	CHEMBL5940	Homo sapiens	Inhibition	%	6.98
	8167638	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.28	CHEMBL5940	Homo sapiens	Inhibition	%	3.28
	8167995	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	6.7	CHEMBL5940	Homo sapiens	Inhibition	%	6.7
	8168119	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.81	CHEMBL5940	Homo sapiens	Inhibition	%	2.81
	8168484	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.33	CHEMBL5940	Homo sapiens	Inhibition	%	4.33
	8168620	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.57	CHEMBL5940	Homo sapiens	Inhibition	%	0.57
	8168844	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.18	CHEMBL5940	Homo sapiens	Inhibition	%	0.18
	8169008	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	15.19	CHEMBL5940	Homo sapiens	Inhibition	%	15.19
	8169374	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.73	CHEMBL5940	Homo sapiens	Inhibition	%	2.73
	8169454	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	6.32	CHEMBL5940	Homo sapiens	Inhibition	%	6.32
	8169678	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	15.99	CHEMBL5940	Homo sapiens	Inhibition	%	15.99
	8169812	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.62	CHEMBL5940	Homo sapiens	Inhibition	%	4.62
	8170181	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-0.19	CHEMBL5940	Homo sapiens	Inhibition	%	-0.19
	8170306	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.81	CHEMBL5940	Homo sapiens	Inhibition	%	1.81
	8170530	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.2	CHEMBL5940	Homo sapiens	Inhibition	%	3.2
	8170670	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	15.49	CHEMBL5940	Homo sapiens	Inhibition	%	15.49
	8170805	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.27	CHEMBL5940	Homo sapiens	Inhibition	%	4.27
	8171029	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.51	CHEMBL5940	Homo sapiens	Inhibition	%	0.51
	8171226	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.59	CHEMBL5940	Homo sapiens	Inhibition	%	2.59
	8171443	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	13.29	CHEMBL5940	Homo sapiens	Inhibition	%	13.29
	8171808	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	11.89	CHEMBL5940	Homo sapiens	Inhibition	%	11.89
	8171961	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.19	CHEMBL5940	Homo sapiens	Inhibition	%	2.19
	8172317	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	6.25	CHEMBL5940	Homo sapiens	Inhibition	%	6.25
	8172445	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	9.5	CHEMBL5940	Homo sapiens	Inhibition	%	9.5
	8172669	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.59	CHEMBL5940	Homo sapiens	Inhibition	%	1.59
	8172811	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.69	CHEMBL5940	Homo sapiens	Inhibition	%	4.69
	8173171	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	4.41	CHEMBL5940	Homo sapiens	Inhibition	%	4.41
	8173336	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.99	CHEMBL5940	Homo sapiens	Inhibition	%	4.99
	8173701	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.31	CHEMBL5940	Homo sapiens	Inhibition	%	4.31
	8174012	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	61.41	CHEMBL5940	Homo sapiens	Inhibition	%	61.41
	8174144	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.55	CHEMBL5940	Homo sapiens	Inhibition	%	2.55
	8174516	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.23	CHEMBL5940	Homo sapiens	Inhibition	%	2.23
	8174862	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.89	CHEMBL5940	Homo sapiens	Inhibition	%	1.89
	8175005	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	61.28	CHEMBL5940	Homo sapiens	Inhibition	%	61.28
	8175365	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.24	CHEMBL5940	Homo sapiens	Inhibition	%	4.24
	8175621	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	25.44	CHEMBL5940	Homo sapiens	Inhibition	%	25.44
	8175784	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.07	CHEMBL5940	Homo sapiens	Inhibition	%	3.07
	8176008	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	4.05	CHEMBL5940	Homo sapiens	Inhibition	%	4.05
	8176161	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.36	CHEMBL5940	Homo sapiens	Inhibition	%	6.36
	8176310	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	6.35	CHEMBL5940	Homo sapiens	Inhibition	%	6.35
	8176534	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	6.96	CHEMBL5940	Homo sapiens	Inhibition	%	6.96
	8176666	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	32.53	CHEMBL5940	Homo sapiens	Inhibition	%	32.53
	8177020	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	3.61	CHEMBL5940	Homo sapiens	Inhibition	%	3.61
	8177162	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	4.55	CHEMBL5940	Homo sapiens	Inhibition	%	4.55
	8177386	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	5.09	CHEMBL5940	Homo sapiens	Inhibition	%	5.09
	8177524	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	7.99	CHEMBL5940	Homo sapiens	Inhibition	%	7.99
	8177688	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	9.17	CHEMBL5940	Homo sapiens	Inhibition	%	9.17
	8177912	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.82	CHEMBL5940	Homo sapiens	Inhibition	%	4.82
	8178052	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	9.1	CHEMBL5940	Homo sapiens	Inhibition	%	9.1
	8178364	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.51	CHEMBL5940	Homo sapiens	Inhibition	%	2.51
	8178491	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.79	CHEMBL5940	Homo sapiens	Inhibition	%	2.79
	8178715	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.33	CHEMBL5940	Homo sapiens	Inhibition	%	3.33
	8178864	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.62	CHEMBL5940	Homo sapiens	Inhibition	%	1.62
	8179211	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.65	CHEMBL5940	Homo sapiens	Inhibition	%	2.65
	8179355	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	7.5	CHEMBL5940	Homo sapiens	Inhibition	%	7.5
	8179579	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	40.71	CHEMBL5940	Homo sapiens	Inhibition	%	40.71
	8179716	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.08	CHEMBL5940	Homo sapiens	Inhibition	%	0.08
	8179973	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.01	CHEMBL5940	Homo sapiens	Inhibition	%	4.01
	8180351	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.53	CHEMBL5940	Homo sapiens	Inhibition	%	1.53
	8180507	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	23.23	CHEMBL5940	Homo sapiens	Inhibition	%	23.23
	8180879	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	36.35	CHEMBL5940	Homo sapiens	Inhibition	%	36.35
	8181012	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	4.73	CHEMBL5940	Homo sapiens	Inhibition	%	4.73
	8181367	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	4.3	CHEMBL5940	Homo sapiens	Inhibition	%	4.3
	8181731	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.97	CHEMBL5940	Homo sapiens	Inhibition	%	4.97
	8181870	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	38.81	CHEMBL5940	Homo sapiens	Inhibition	%	38.81
	8182257	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	7.14	CHEMBL5940	Homo sapiens	Inhibition	%	7.14
	8182397	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.43	CHEMBL5940	Homo sapiens	Inhibition	%	3.43
	8182713	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.11	CHEMBL5940	Homo sapiens	Inhibition	%	2.11
	8183059	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.14	CHEMBL5940	Homo sapiens	Inhibition	%	5.14
	8183208	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.2	CHEMBL5940	Homo sapiens	Inhibition	%	1.2
	8183432	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.37	CHEMBL5940	Homo sapiens	Inhibition	%	2.37
	8183561	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	4.61	CHEMBL5940	Homo sapiens	Inhibition	%	4.61
	8183927	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.26	CHEMBL5940	Homo sapiens	Inhibition	%	3.26
	8184063	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.29	CHEMBL5940	Homo sapiens	Inhibition	%	0.29
	8184329	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.96	CHEMBL5940	Homo sapiens	Inhibition	%	5.96
	8184700	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.14	CHEMBL5940	Homo sapiens	Inhibition	%	2.14
	8184857	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.97	CHEMBL5940	Homo sapiens	Inhibition	%	1.97
	8185081	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	3.47	CHEMBL5940	Homo sapiens	Inhibition	%	3.47
	8185230	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.88	CHEMBL5940	Homo sapiens	Inhibition	%	1.88
	8185361	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	7.33	CHEMBL5940	Homo sapiens	Inhibition	%	7.33
	8185585	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.11	CHEMBL5940	Homo sapiens	Inhibition	%	5.11
	8185716	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	32.78	CHEMBL5940	Homo sapiens	Inhibition	%	32.78
	8186079	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	9.42	CHEMBL5940	Homo sapiens	Inhibition	%	9.42
	8186220	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.53	CHEMBL5940	Homo sapiens	Inhibition	%	4.53
	8186444	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	8.38	CHEMBL5940	Homo sapiens	Inhibition	%	8.38
	8186608	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.48	CHEMBL5940	Homo sapiens	Inhibition	%	3.48
	8186747	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.46	CHEMBL5940	Homo sapiens	Inhibition	%	4.46
	8186971	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.47	CHEMBL5940	Homo sapiens	Inhibition	%	4.47
	8187069	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.85	CHEMBL5940	Homo sapiens	Inhibition	%	2.85
	8187417	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.92	CHEMBL5940	Homo sapiens	Inhibition	%	2.92
	8187789	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.28	CHEMBL5940	Homo sapiens	Inhibition	%	2.28
	8187918	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.64	CHEMBL5940	Homo sapiens	Inhibition	%	6.64
	8188285	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	11.38	CHEMBL5940	Homo sapiens	Inhibition	%	11.38
	8188420	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.85	CHEMBL5940	Homo sapiens	Inhibition	%	0.85
	8188644	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	4.83	CHEMBL5940	Homo sapiens	Inhibition	%	4.83
	8188694	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.44	CHEMBL5940	Homo sapiens	Inhibition	%	3.44
	8188918	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.0	CHEMBL5940	Homo sapiens	Inhibition	%	6.0
	8189066	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	2.39	CHEMBL5940	Homo sapiens	Inhibition	%	2.39
	8189446	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	6.31	CHEMBL5940	Homo sapiens	Inhibition	%	6.31
	8189595	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.89	CHEMBL5940	Homo sapiens	Inhibition	%	2.89
	8189951	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	8.02	CHEMBL5940	Homo sapiens	Inhibition	%	8.02
	8190083	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.43	CHEMBL5940	Homo sapiens	Inhibition	%	3.43
	8190307	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	7.22	CHEMBL5940	Homo sapiens	Inhibition	%	7.22
	8190447	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.42	CHEMBL5940	Homo sapiens	Inhibition	%	4.42
	8190808	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.31	CHEMBL5940	Homo sapiens	Inhibition	%	3.31
	8190972	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.45	CHEMBL5940	Homo sapiens	Inhibition	%	5.45
	8191334	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	9.32	CHEMBL5940	Homo sapiens	Inhibition	%	9.32
	8191430	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	3.03	CHEMBL5940	Homo sapiens	Inhibition	%	3.03
	8191654	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.66	CHEMBL5940	Homo sapiens	Inhibition	%	1.66
	8191776	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.68	CHEMBL5940	Homo sapiens	Inhibition	%	6.68
	8192149	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.27	CHEMBL5940	Homo sapiens	Inhibition	%	1.27
	8192278	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.53	CHEMBL5940	Homo sapiens	Inhibition	%	1.53
	8192502	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.91	CHEMBL5940	Homo sapiens	Inhibition	%	2.91
	8192646	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.55	CHEMBL5940	Homo sapiens	Inhibition	%	2.55
	8193006	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.04	CHEMBL5940	Homo sapiens	Inhibition	%	-0.04
	8193278	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.29	CHEMBL5940	Homo sapiens	Inhibition	%	2.29
	8193423	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	4.77	CHEMBL5940	Homo sapiens	Inhibition	%	4.77
	8193804	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	24.38	CHEMBL5940	Homo sapiens	Inhibition	%	24.38
	8193953	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.71	CHEMBL5940	Homo sapiens	Inhibition	%	0.71
	8194177	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.75	CHEMBL5940	Homo sapiens	Inhibition	%	2.75
	8194308	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.14	CHEMBL5940	Homo sapiens	Inhibition	%	4.14
	8194663	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.93	CHEMBL5940	Homo sapiens	Inhibition	%	3.93
	8194806	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	8.02	CHEMBL5940	Homo sapiens	Inhibition	%	8.02
	8195163	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	7.7	CHEMBL5940	Homo sapiens	Inhibition	%	7.7
	8195327	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.54	CHEMBL5940	Homo sapiens	Inhibition	%	3.54
	8195551	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	14.25	CHEMBL5940	Homo sapiens	Inhibition	%	14.25
	8195690	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.66	CHEMBL5940	Homo sapiens	Inhibition	%	4.66
	8196012	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.38	CHEMBL5940	Homo sapiens	Inhibition	%	4.38
	8196129	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.85	CHEMBL5940	Homo sapiens	Inhibition	%	1.85
	8196353	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	6.13	CHEMBL5940	Homo sapiens	Inhibition	%	6.13
	8196503	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.17	CHEMBL5940	Homo sapiens	Inhibition	%	2.17
	8196855	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.63	CHEMBL5940	Homo sapiens	Inhibition	%	2.63
	8196996	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	7.06	CHEMBL5940	Homo sapiens	Inhibition	%	7.06
	8197357	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.77	CHEMBL5940	Homo sapiens	Inhibition	%	2.77
	8197632	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.17	CHEMBL5940	Homo sapiens	Inhibition	%	4.17
	8197772	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.4	CHEMBL5940	Homo sapiens	Inhibition	%	2.4
	8197996	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	9.28	CHEMBL5940	Homo sapiens	Inhibition	%	9.28
	8198153	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.51	CHEMBL5940	Homo sapiens	Inhibition	%	4.51
	8198515	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.11	CHEMBL5940	Homo sapiens	Inhibition	%	4.11
	8198645	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	7.86	CHEMBL5940	Homo sapiens	Inhibition	%	7.86
	8199000	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.85	CHEMBL5940	Homo sapiens	Inhibition	%	5.85
	8199148	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.62	CHEMBL5940	Homo sapiens	Inhibition	%	3.62
	8199372	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.59	CHEMBL5940	Homo sapiens	Inhibition	%	5.59
	8199506	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.09	CHEMBL5940	Homo sapiens	Inhibition	%	4.09
	8199893	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.3	CHEMBL5940	Homo sapiens	Inhibition	%	2.3
	8200031	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.32	CHEMBL5940	Homo sapiens	Inhibition	%	4.32
	8200359	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.31	CHEMBL5940	Homo sapiens	Inhibition	%	1.31
	8200698	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	7.13	CHEMBL5940	Homo sapiens	Inhibition	%	7.13
	8200848	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.96	CHEMBL5940	Homo sapiens	Inhibition	%	2.96
	8201202	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	15.76	CHEMBL5940	Homo sapiens	Inhibition	%	15.76
	8201337	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.77	CHEMBL5940	Homo sapiens	Inhibition	%	0.77
	8201561	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.63	CHEMBL5940	Homo sapiens	Inhibition	%	3.63
	8201694	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.01	CHEMBL5940	Homo sapiens	Inhibition	%	-1.01
	8201973	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.68	CHEMBL5940	Homo sapiens	Inhibition	%	3.68
	8202337	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.42	CHEMBL5940	Homo sapiens	Inhibition	%	0.42
	8202504	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.67	CHEMBL5940	Homo sapiens	Inhibition	%	4.67
	8202853	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.39	CHEMBL5940	Homo sapiens	Inhibition	%	3.39
	8202983	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.41	CHEMBL5940	Homo sapiens	Inhibition	%	4.41
	8203207	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	9.02	CHEMBL5940	Homo sapiens	Inhibition	%	9.02
	8203338	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	4.13	CHEMBL5940	Homo sapiens	Inhibition	%	4.13
	8203708	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.78	CHEMBL5940	Homo sapiens	Inhibition	%	1.78
	8203842	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.61	CHEMBL5940	Homo sapiens	Inhibition	%	5.61
	8204066	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.2	CHEMBL5940	Homo sapiens	Inhibition	%	5.2
	8204232	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.93	CHEMBL5940	Homo sapiens	Inhibition	%	2.93
	8204369	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.13	CHEMBL5940	Homo sapiens	Inhibition	%	4.13
	8204593	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	6.28	CHEMBL5940	Homo sapiens	Inhibition	%	6.28
	8204698	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.37	CHEMBL5940	Homo sapiens	Inhibition	%	0.37
	8205037	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	35.72	CHEMBL5940	Homo sapiens	Inhibition	%	35.72
	8205186	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.55	CHEMBL5940	Homo sapiens	Inhibition	%	3.55
	8205410	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	10.29	CHEMBL5940	Homo sapiens	Inhibition	%	10.29
	8205546	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.58	CHEMBL5940	Homo sapiens	Inhibition	%	2.58
	8205909	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.05	CHEMBL5940	Homo sapiens	Inhibition	%	2.05
	8206041	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.81	CHEMBL5940	Homo sapiens	Inhibition	%	-1.81
	8206265	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.56	CHEMBL5940	Homo sapiens	Inhibition	%	-2.56
	8206317	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.33	CHEMBL5940	Homo sapiens	Inhibition	%	3.33
	8206541	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.82	CHEMBL5940	Homo sapiens	Inhibition	%	2.82
	8206684	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.58	CHEMBL5940	Homo sapiens	Inhibition	%	1.58
	8206864	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.64	CHEMBL5940	Homo sapiens	Inhibition	%	3.64
	8207088	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.1	CHEMBL5940	Homo sapiens	Inhibition	%	6.1
	8207214	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.51	CHEMBL5940	Homo sapiens	Inhibition	%	5.51
	8207568	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	3.94	CHEMBL5940	Homo sapiens	Inhibition	%	3.94
	8207700	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	7.61	CHEMBL5940	Homo sapiens	Inhibition	%	7.61
	8207924	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.91	CHEMBL5940	Homo sapiens	Inhibition	%	5.91
	8208069	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.05	CHEMBL5940	Homo sapiens	Inhibition	%	5.05
	8208425	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	7.25	CHEMBL5940	Homo sapiens	Inhibition	%	7.25
	8208591	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.86	CHEMBL5940	Homo sapiens	Inhibition	%	1.86
	8208948	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	6.69	CHEMBL5940	Homo sapiens	Inhibition	%	6.69
	8209053	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.41	CHEMBL5940	Homo sapiens	Inhibition	%	1.41
	8209277	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.75	CHEMBL5940	Homo sapiens	Inhibition	%	0.75
	8209393	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.28	CHEMBL5940	Homo sapiens	Inhibition	%	3.28
	8209767	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.75	CHEMBL5940	Homo sapiens	Inhibition	%	1.75
	8209903	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	9.64	CHEMBL5940	Homo sapiens	Inhibition	%	9.64
	8210127	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	5.95	CHEMBL5940	Homo sapiens	Inhibition	%	5.95
	8210268	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.04	CHEMBL5940	Homo sapiens	Inhibition	%	2.04
	8210628	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.05	CHEMBL5940	Homo sapiens	Inhibition	%	-1.05
	8210887	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	4.92	CHEMBL5940	Homo sapiens	Inhibition	%	4.92
	8211031	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.71	CHEMBL5940	Homo sapiens	Inhibition	%	2.71
	8211425	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.09	CHEMBL5940	Homo sapiens	Inhibition	%	4.09
	8211548	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.17	CHEMBL5940	Homo sapiens	Inhibition	%	4.17
	8211901	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	9.58	CHEMBL5940	Homo sapiens	Inhibition	%	9.58
	8212257	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	9.52	CHEMBL5940	Homo sapiens	Inhibition	%	9.52
	8212398	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.81	CHEMBL5940	Homo sapiens	Inhibition	%	3.81
	8212755	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.06	CHEMBL5940	Homo sapiens	Inhibition	%	4.06
	8212925	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.48	CHEMBL5940	Homo sapiens	Inhibition	%	3.48
	8213278	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	23.23	CHEMBL5940	Homo sapiens	Inhibition	%	23.23
	8213606	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.68	CHEMBL5940	Homo sapiens	Inhibition	%	-0.68
	8213719	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	6.18	CHEMBL5940	Homo sapiens	Inhibition	%	6.18
	8213943	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.54	CHEMBL5940	Homo sapiens	Inhibition	%	2.54
	8214090	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.18	CHEMBL5940	Homo sapiens	Inhibition	%	2.18
	8214451	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	31.9	CHEMBL5940	Homo sapiens	Inhibition	%	31.9
	8214585	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.3	CHEMBL5940	Homo sapiens	Inhibition	%	2.3
	8214961	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.58	CHEMBL5940	Homo sapiens	Inhibition	%	4.58
	8215212	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.81	CHEMBL5940	Homo sapiens	Inhibition	%	3.81
	8215365	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	6.82	CHEMBL5940	Homo sapiens	Inhibition	%	6.82
	8215589	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.41	CHEMBL5940	Homo sapiens	Inhibition	%	4.41
	8215753	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.3	CHEMBL5940	Homo sapiens	Inhibition	%	3.3
	8215872	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.88	CHEMBL5940	Homo sapiens	Inhibition	%	3.88
	8216096	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	7.69	CHEMBL5940	Homo sapiens	Inhibition	%	7.69
	8216215	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.69	CHEMBL5940	Homo sapiens	Inhibition	%	2.69
	8216575	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	8.64	CHEMBL5940	Homo sapiens	Inhibition	%	8.64
	8216713	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.7	CHEMBL5940	Homo sapiens	Inhibition	%	5.7
	8216937	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.73	CHEMBL5940	Homo sapiens	Inhibition	%	4.73
	8217071	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.5	CHEMBL5940	Homo sapiens	Inhibition	%	6.5
	8217245	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.66	CHEMBL5940	Homo sapiens	Inhibition	%	1.66
	8217469	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.44	CHEMBL5940	Homo sapiens	Inhibition	%	0.44
	8217600	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	36.86	CHEMBL5940	Homo sapiens	Inhibition	%	36.86
	8217925	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.26	CHEMBL5940	Homo sapiens	Inhibition	%	-0.26
	8218264	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.97	CHEMBL5940	Homo sapiens	Inhibition	%	3.97
	8218391	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	4.25	CHEMBL5940	Homo sapiens	Inhibition	%	4.25
	8218758	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.02	CHEMBL5940	Homo sapiens	Inhibition	%	3.02
	8218889	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	6.45	CHEMBL5940	Homo sapiens	Inhibition	%	6.45
	8219113	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.51	CHEMBL5940	Homo sapiens	Inhibition	%	2.51
	8219273	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.86	CHEMBL5940	Homo sapiens	Inhibition	%	4.86
	8219523	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	6.99	CHEMBL5940	Homo sapiens	Inhibition	%	6.99
	8219908	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.73	CHEMBL5940	Homo sapiens	Inhibition	%	3.73
	8220077	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.52	CHEMBL5940	Homo sapiens	Inhibition	%	3.52
	8220430	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.74	CHEMBL5940	Homo sapiens	Inhibition	%	4.74
	8220544	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.02	CHEMBL5940	Homo sapiens	Inhibition	%	4.02
	8220768	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.77	CHEMBL5940	Homo sapiens	Inhibition	%	3.77
	8220906	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	33.76	CHEMBL5940	Homo sapiens	Inhibition	%	33.76
	8221266	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	20.64	CHEMBL5940	Homo sapiens	Inhibition	%	20.64
	8221399	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.19	CHEMBL5940	Homo sapiens	Inhibition	%	3.19
	8221788	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.71	CHEMBL5940	Homo sapiens	Inhibition	%	1.71
	8221919	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	80.0	CHEMBL5940	Homo sapiens	Inhibition	%	80.0
	8222143	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.72	CHEMBL5940	Homo sapiens	Inhibition	%	5.72
	8222241	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.61	CHEMBL5940	Homo sapiens	Inhibition	%	1.61
	8222599	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.62	CHEMBL5940	Homo sapiens	Inhibition	%	3.62
	8222717	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	16.68	CHEMBL5940	Homo sapiens	Inhibition	%	16.68
	8222941	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.38	CHEMBL5940	Homo sapiens	Inhibition	%	1.38
	8223085	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	6.8	CHEMBL5940	Homo sapiens	Inhibition	%	6.8
	8223438	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	5.14	CHEMBL5940	Homo sapiens	Inhibition	%	5.14
	8223599	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.6	CHEMBL5940	Homo sapiens	Inhibition	%	2.6
	8223849	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.38	CHEMBL5940	Homo sapiens	Inhibition	%	3.38
	8224235	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.49	CHEMBL5940	Homo sapiens	Inhibition	%	5.49
	8224405	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.83	CHEMBL5940	Homo sapiens	Inhibition	%	2.83
	8224764	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	6.78	CHEMBL5940	Homo sapiens	Inhibition	%	6.78
	8225102	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	6.87	CHEMBL5940	Homo sapiens	Inhibition	%	6.87
	8225236	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.12	CHEMBL5940	Homo sapiens	Inhibition	%	5.12
	8225598	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.87	CHEMBL5940	Homo sapiens	Inhibition	%	1.87
	8225733	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	8.61	CHEMBL5940	Homo sapiens	Inhibition	%	8.61
	8225957	CHEMBL1961972	GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.32	CHEMBL5940	Homo sapiens	Inhibition	%	4.32
	8226115	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.51	CHEMBL5940	Homo sapiens	Inhibition	%	1.51
	8226464	CHEMBL1961973	GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	10.44	CHEMBL5940	Homo sapiens	Inhibition	%	10.44
	10839396	CHEMBL2014962	Inhibition of MARK1 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	48.0	CHEMBL5940	Homo sapiens	INH	%	48.0
	10839573	CHEMBL2015151	Inhibition of MARK1 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	13.0	CHEMBL5940	Homo sapiens	Activity	%	13.0
	10839633	CHEMBL2016283	Inhibition of MARK1 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	36.0	CHEMBL5940	Homo sapiens	Activity	%	36.0
	10978457	CHEMBL2066250	Inhibition of human recombinant MARK1 using ulight-RRRSLLE as substrate assessed as residual activity at 1 uM after 30 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL5940	Homo sapiens	Activity	%	80.0
	10980026	CHEMBL2067485	Inhibition of MARK at 1000 nM	B	CN(C)C[C@@H](OC(=O)N1Cc2c(NC(=O)C(C)(C)C)n[nH]c2C1(C)C)c1ccccc1		CHEMBL2064628	>	Inhibition	%	70.0	CHEMBL5940	Homo sapiens	INH	%	70.0
	10980029	CHEMBL2067488	Inhibition of MARK1	B	CN(C)C[C@@H](OC(=O)N1Cc2c(NC(=O)C(C)(C)C)n[nH]c2C1(C)C)c1ccccc1		CHEMBL2064628	=	IC50	nM	115.0	CHEMBL5940	Homo sapiens	IC50	nM	115.0
	10980060	CHEMBL2067485	Inhibition of MARK at 1000 nM	B	CN(C)C[C@@H](OC(=O)N1Cc2c(NC(=O)C(C)(C)C(F)(F)F)n[nH]c2C1(C)C)c1ccccc1		CHEMBL2064631	>	Inhibition	%	70.0	CHEMBL5940	Homo sapiens	INH	%	70.0
	12046354	CHEMBL2157281	Inhibition of MARK1 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	4.0	CHEMBL5940	Homo sapiens	INH	%	4.0
	12166115	CHEMBL2211589	Binding affinity to MARK1 at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL5940	Homo sapiens	Activity	%	50.0
	12170787	CHEMBL2209913	Inhibition of MARK1 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	85.0	CHEMBL5940	Homo sapiens	Activity	%	85.0
	12170918	CHEMBL2213914	Inhibition of MARK1 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	88.0	CHEMBL5940	Homo sapiens	Activity	%	88.0
	12172360	CHEMBL2210625	Inhibition of MARK1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	96.0	CHEMBL5940	Homo sapiens	Activity	%	96.0
	12195601	CHEMBL2212380	Inhibition of human recombinant MARK1 using Ulight-RRRSLLE as substrate assessed as residual activity at 1 uM after 30 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	99.6	CHEMBL5940	Homo sapiens	Activity	%	99.6
	12206722	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	93.0	CHEMBL5940	Homo sapiens	Residual Activity	%	93.0
	12206723	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	80.0	CHEMBL5940	Homo sapiens	Residual Activity	%	80.0
	12206724	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	73.0	CHEMBL5940	Homo sapiens	Residual Activity	%	73.0
	12206725	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	73.0	CHEMBL5940	Homo sapiens	Residual Activity	%	73.0
	12206726	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	78.0	CHEMBL5940	Homo sapiens	Residual Activity	%	78.0
	12206727	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	85.0	CHEMBL5940	Homo sapiens	Residual Activity	%	85.0
	12206728	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	72.0	CHEMBL5940	Homo sapiens	Residual Activity	%	72.0
	12206729	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	106.0	CHEMBL5940	Homo sapiens	Residual Activity	%	106.0
	12206730	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	93.0	CHEMBL5940	Homo sapiens	Residual Activity	%	93.0
	12206731	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	4.0	CHEMBL5940	Homo sapiens	Residual Activity	%	4.0
	12206732	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	1.0	CHEMBL5940	Homo sapiens	Residual Activity	%	1.0
	12206733	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	81.0	CHEMBL5940	Homo sapiens	Residual Activity	%	81.0
	12206734	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	81.0	CHEMBL5940	Homo sapiens	Residual Activity	%	81.0
	12206735	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	85.0	CHEMBL5940	Homo sapiens	Residual Activity	%	85.0
	12206736	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	65.0	CHEMBL5940	Homo sapiens	Residual Activity	%	65.0
	12206737	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	107.0	CHEMBL5940	Homo sapiens	Residual Activity	%	107.0
	12206738	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	104.0	CHEMBL5940	Homo sapiens	Residual Activity	%	104.0
	12206739	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	75.0	CHEMBL5940	Homo sapiens	Residual Activity	%	75.0
	12206740	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	74.0	CHEMBL5940	Homo sapiens	Residual Activity	%	74.0
	12206741	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	9.0	CHEMBL5940	Homo sapiens	Residual Activity	%	9.0
	12206742	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	73.0	CHEMBL5940	Homo sapiens	Residual Activity	%	73.0
	12206743	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	85.0	CHEMBL5940	Homo sapiens	Residual Activity	%	85.0
	12206744	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	91.0	CHEMBL5940	Homo sapiens	Residual Activity	%	91.0
	12206745	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	105.0	CHEMBL5940	Homo sapiens	Residual Activity	%	105.0
	12206746	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	100.0	CHEMBL5940	Homo sapiens	Residual Activity	%	100.0
	12206747	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	69.0	CHEMBL5940	Homo sapiens	Residual Activity	%	69.0
	12206748	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	83.0	CHEMBL5940	Homo sapiens	Residual Activity	%	83.0
	12206749	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	69.0	CHEMBL5940	Homo sapiens	Residual Activity	%	69.0
	12206750	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	1.0	CHEMBL5940	Homo sapiens	Residual Activity	%	1.0
	12206751	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	89.0	CHEMBL5940	Homo sapiens	Residual Activity	%	89.0
	12206752	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	93.0	CHEMBL5940	Homo sapiens	Residual Activity	%	93.0
	12206753	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	104.0	CHEMBL5940	Homo sapiens	Residual Activity	%	104.0
	12206754	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	83.0	CHEMBL5940	Homo sapiens	Residual Activity	%	83.0
	12206755	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	92.0	CHEMBL5940	Homo sapiens	Residual Activity	%	92.0
	12206756	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	82.0	CHEMBL5940	Homo sapiens	Residual Activity	%	82.0
	12206757	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	86.0	CHEMBL5940	Homo sapiens	Residual Activity	%	86.0
	12206758	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	83.0	CHEMBL5940	Homo sapiens	Residual Activity	%	83.0
	12206759	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	84.0	CHEMBL5940	Homo sapiens	Residual Activity	%	84.0
	12206760	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	93.0	CHEMBL5940	Homo sapiens	Residual Activity	%	93.0
	12206761	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	65.0	CHEMBL5940	Homo sapiens	Residual Activity	%	65.0
	12206762	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	104.0	CHEMBL5940	Homo sapiens	Residual Activity	%	104.0
	12206763	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	86.0	CHEMBL5940	Homo sapiens	Residual Activity	%	86.0
	12206764	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	44.0	CHEMBL5940	Homo sapiens	Residual Activity	%	44.0
	12206765	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	100.0	CHEMBL5940	Homo sapiens	Residual Activity	%	100.0
	12206766	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	14.0	CHEMBL5940	Homo sapiens	Residual Activity	%	14.0
	12206767	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	90.0	CHEMBL5940	Homo sapiens	Residual Activity	%	90.0
	12206768	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL5940	Homo sapiens	Residual Activity	%	-1.0
	12206769	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	99.0	CHEMBL5940	Homo sapiens	Residual Activity	%	99.0
	12206770	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	44.0	CHEMBL5940	Homo sapiens	Residual Activity	%	44.0
	12206771	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	67.0	CHEMBL5940	Homo sapiens	Residual Activity	%	67.0
	12206772	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	95.0	CHEMBL5940	Homo sapiens	Residual Activity	%	95.0
	12206773	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	24.0	CHEMBL5940	Homo sapiens	Residual Activity	%	24.0
	12206774	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	102.0	CHEMBL5940	Homo sapiens	Residual Activity	%	102.0
	12206775	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	94.0	CHEMBL5940	Homo sapiens	Residual Activity	%	94.0
	12206776	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	105.0	CHEMBL5940	Homo sapiens	Residual Activity	%	105.0
	12206777	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	104.0	CHEMBL5940	Homo sapiens	Residual Activity	%	104.0
	12206778	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	37.0	CHEMBL5940	Homo sapiens	Residual Activity	%	37.0
	12206779	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	87.0	CHEMBL5940	Homo sapiens	Residual Activity	%	87.0
	12206780	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	83.0	CHEMBL5940	Homo sapiens	Residual Activity	%	83.0
	12206781	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	66.0	CHEMBL5940	Homo sapiens	Residual Activity	%	66.0
	12206782	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	92.0	CHEMBL5940	Homo sapiens	Residual Activity	%	92.0
	12206783	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	100.0	CHEMBL5940	Homo sapiens	Residual Activity	%	100.0
	12206784	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	106.0	CHEMBL5940	Homo sapiens	Residual Activity	%	106.0
	12206785	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	96.0	CHEMBL5940	Homo sapiens	Residual Activity	%	96.0
	12206786	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	90.0	CHEMBL5940	Homo sapiens	Residual Activity	%	90.0
	12206787	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	87.0	CHEMBL5940	Homo sapiens	Residual Activity	%	87.0
	12206788	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	75.0	CHEMBL5940	Homo sapiens	Residual Activity	%	75.0
	12206789	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	25.0	CHEMBL5940	Homo sapiens	Residual Activity	%	25.0
	12206790	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL5940	Homo sapiens	Residual Activity	%	0.0
	12206791	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	87.0	CHEMBL5940	Homo sapiens	Residual Activity	%	87.0
	12206792	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	38.0	CHEMBL5940	Homo sapiens	Residual Activity	%	38.0
	12206793	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	34.0	CHEMBL5940	Homo sapiens	Residual Activity	%	34.0
	12206794	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	81.0	CHEMBL5940	Homo sapiens	Residual Activity	%	81.0
	12206795	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	67.0	CHEMBL5940	Homo sapiens	Residual Activity	%	67.0
	12206796	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	80.0	CHEMBL5940	Homo sapiens	Residual Activity	%	80.0
	12206797	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	89.0	CHEMBL5940	Homo sapiens	Residual Activity	%	89.0
	12206798	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	51.0	CHEMBL5940	Homo sapiens	Residual Activity	%	51.0
	12206799	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	91.0	CHEMBL5940	Homo sapiens	Residual Activity	%	91.0
	12206800	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	97.0	CHEMBL5940	Homo sapiens	Residual Activity	%	97.0
	12206801	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	30.0	CHEMBL5940	Homo sapiens	Residual Activity	%	30.0
	12206802	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	92.0	CHEMBL5940	Homo sapiens	Residual Activity	%	92.0
	12206803	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	85.0	CHEMBL5940	Homo sapiens	Residual Activity	%	85.0
	12206804	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	76.0	CHEMBL5940	Homo sapiens	Residual Activity	%	76.0
	12206805	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	57.0	CHEMBL5940	Homo sapiens	Residual Activity	%	57.0
	12206806	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	83.0	CHEMBL5940	Homo sapiens	Residual Activity	%	83.0
	12206807	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	89.0	CHEMBL5940	Homo sapiens	Residual Activity	%	89.0
	12206808	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	105.0	CHEMBL5940	Homo sapiens	Residual Activity	%	105.0
	12206809	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	74.0	CHEMBL5940	Homo sapiens	Residual Activity	%	74.0
	12206810	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	77.0	CHEMBL5940	Homo sapiens	Residual Activity	%	77.0
	12206811	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	50.0	CHEMBL5940	Homo sapiens	Residual Activity	%	50.0
	12206812	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	4.0	CHEMBL5940	Homo sapiens	Residual Activity	%	4.0
	12206813	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	40.0	CHEMBL5940	Homo sapiens	Residual Activity	%	40.0
	12206814	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	83.0	CHEMBL5940	Homo sapiens	Residual Activity	%	83.0
	12206815	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	78.0	CHEMBL5940	Homo sapiens	Residual Activity	%	78.0
	12206816	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	104.0	CHEMBL5940	Homo sapiens	Residual Activity	%	104.0
	12206817	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	78.0	CHEMBL5940	Homo sapiens	Residual Activity	%	78.0
	12206818	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-1.0	CHEMBL5940	Homo sapiens	Residual Activity	%	-1.0
	12206819	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	85.0	CHEMBL5940	Homo sapiens	Residual Activity	%	85.0
	12206820	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	85.0	CHEMBL5940	Homo sapiens	Residual Activity	%	85.0
	12206821	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	38.0	CHEMBL5940	Homo sapiens	Residual Activity	%	38.0
	12206822	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	82.0	CHEMBL5940	Homo sapiens	Residual Activity	%	82.0
	12206823	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	51.0	CHEMBL5940	Homo sapiens	Residual Activity	%	51.0
	12206824	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	92.0	CHEMBL5940	Homo sapiens	Residual Activity	%	92.0
	12206825	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	75.0	CHEMBL5940	Homo sapiens	Residual Activity	%	75.0
	12206826	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	60.0	CHEMBL5940	Homo sapiens	Residual Activity	%	60.0
	12206827	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	21.0	CHEMBL5940	Homo sapiens	Residual Activity	%	21.0
	12206828	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	76.0	CHEMBL5940	Homo sapiens	Residual Activity	%	76.0
	12206829	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	72.0	CHEMBL5940	Homo sapiens	Residual Activity	%	72.0
	12206830	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	76.0	CHEMBL5940	Homo sapiens	Residual Activity	%	76.0
	12206831	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	81.0	CHEMBL5940	Homo sapiens	Residual Activity	%	81.0
	12206832	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	60.0	CHEMBL5940	Homo sapiens	Residual Activity	%	60.0
	12206833	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	96.0	CHEMBL5940	Homo sapiens	Residual Activity	%	96.0
	12206834	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	80.0	CHEMBL5940	Homo sapiens	Residual Activity	%	80.0
	12206835	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	77.0	CHEMBL5940	Homo sapiens	Residual Activity	%	77.0
	12206836	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	85.0	CHEMBL5940	Homo sapiens	Residual Activity	%	85.0
	12206837	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	88.0	CHEMBL5940	Homo sapiens	Residual Activity	%	88.0
	12206838	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	90.0	CHEMBL5940	Homo sapiens	Residual Activity	%	90.0
	12206839	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	32.0	CHEMBL5940	Homo sapiens	Residual Activity	%	32.0
	12206840	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	104.0	CHEMBL5940	Homo sapiens	Residual Activity	%	104.0
	12206841	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	98.0	CHEMBL5940	Homo sapiens	Residual Activity	%	98.0
	12206842	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	81.0	CHEMBL5940	Homo sapiens	Residual Activity	%	81.0
	12206843	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	100.0	CHEMBL5940	Homo sapiens	Residual Activity	%	100.0
	12206844	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	87.0	CHEMBL5940	Homo sapiens	Residual Activity	%	87.0
	12206845	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	95.0	CHEMBL5940	Homo sapiens	Residual Activity	%	95.0
	12206846	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	-1.0	CHEMBL5940	Homo sapiens	Residual Activity	%	-1.0
	12206847	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	93.0	CHEMBL5940	Homo sapiens	Residual Activity	%	93.0
	12206848	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	37.0	CHEMBL5940	Homo sapiens	Residual Activity	%	37.0
	12206849	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	79.0	CHEMBL5940	Homo sapiens	Residual Activity	%	79.0
	12206850	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	77.0	CHEMBL5940	Homo sapiens	Residual Activity	%	77.0
	12206851	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	73.0	CHEMBL5940	Homo sapiens	Residual Activity	%	73.0
	12206852	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	88.0	CHEMBL5940	Homo sapiens	Residual Activity	%	88.0
	12206853	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	7.0	CHEMBL5940	Homo sapiens	Residual Activity	%	7.0
	12206854	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	83.0	CHEMBL5940	Homo sapiens	Residual Activity	%	83.0
	12206855	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	100.0	CHEMBL5940	Homo sapiens	Residual Activity	%	100.0
	12206856	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	94.0	CHEMBL5940	Homo sapiens	Residual Activity	%	94.0
	12206857	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	83.0	CHEMBL5940	Homo sapiens	Residual Activity	%	83.0
	12206858	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	81.0	CHEMBL5940	Homo sapiens	Residual Activity	%	81.0
	12206859	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	90.0	CHEMBL5940	Homo sapiens	Residual Activity	%	90.0
	12206860	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	80.0	CHEMBL5940	Homo sapiens	Residual Activity	%	80.0
	12206861	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	30.0	CHEMBL5940	Homo sapiens	Residual Activity	%	30.0
	12206862	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	87.0	CHEMBL5940	Homo sapiens	Residual Activity	%	87.0
	12206863	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	111.0	CHEMBL5940	Homo sapiens	Residual Activity	%	111.0
	12206864	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	91.0	CHEMBL5940	Homo sapiens	Residual Activity	%	91.0
	12206865	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	81.0	CHEMBL5940	Homo sapiens	Residual Activity	%	81.0
	12206866	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	14.0	CHEMBL5940	Homo sapiens	Residual Activity	%	14.0
	12206867	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	84.0	CHEMBL5940	Homo sapiens	Residual Activity	%	84.0
	12206868	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	75.0	CHEMBL5940	Homo sapiens	Residual Activity	%	75.0
	12206869	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	85.0	CHEMBL5940	Homo sapiens	Residual Activity	%	85.0
	12206870	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	87.0	CHEMBL5940	Homo sapiens	Residual Activity	%	87.0
	12206871	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	102.0	CHEMBL5940	Homo sapiens	Residual Activity	%	102.0
	12206872	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	69.0	CHEMBL5940	Homo sapiens	Residual Activity	%	69.0
	12206873	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	5.0	CHEMBL5940	Homo sapiens	Residual Activity	%	5.0
	12206874	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	54.0	CHEMBL5940	Homo sapiens	Residual Activity	%	54.0
	12206875	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	78.0	CHEMBL5940	Homo sapiens	Residual Activity	%	78.0
	12206876	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	51.0	CHEMBL5940	Homo sapiens	Residual Activity	%	51.0
	12206877	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	81.0	CHEMBL5940	Homo sapiens	Residual Activity	%	81.0
	12206878	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	80.0	CHEMBL5940	Homo sapiens	Residual Activity	%	80.0
	12206879	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	90.0	CHEMBL5940	Homo sapiens	Residual Activity	%	90.0
	12206880	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	89.0	CHEMBL5940	Homo sapiens	Residual Activity	%	89.0
	12206881	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	71.0	CHEMBL5940	Homo sapiens	Residual Activity	%	71.0
	12206882	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	75.0	CHEMBL5940	Homo sapiens	Residual Activity	%	75.0
	12206883	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	48.0	CHEMBL5940	Homo sapiens	Residual Activity	%	48.0
	12206884	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	71.0	CHEMBL5940	Homo sapiens	Residual Activity	%	71.0
	12206885	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	77.0	CHEMBL5940	Homo sapiens	Residual Activity	%	77.0
	12206886	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	59.0	CHEMBL5940	Homo sapiens	Residual Activity	%	59.0
	12206887	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	106.0	CHEMBL5940	Homo sapiens	Residual Activity	%	106.0
	12206888	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	91.0	CHEMBL5940	Homo sapiens	Residual Activity	%	91.0
	12206889	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	5.0	CHEMBL5940	Homo sapiens	Residual Activity	%	5.0
	12206890	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	0.0	CHEMBL5940	Homo sapiens	Residual Activity	%	0.0
	12206891	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	75.0	CHEMBL5940	Homo sapiens	Residual Activity	%	75.0
	12206892	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	77.0	CHEMBL5940	Homo sapiens	Residual Activity	%	77.0
	12206893	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	91.0	CHEMBL5940	Homo sapiens	Residual Activity	%	91.0
	12206894	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	20.0	CHEMBL5940	Homo sapiens	Residual Activity	%	20.0
	12206895	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	104.0	CHEMBL5940	Homo sapiens	Residual Activity	%	104.0
	12206896	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	95.0	CHEMBL5940	Homo sapiens	Residual Activity	%	95.0
	12206897	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	53.0	CHEMBL5940	Homo sapiens	Residual Activity	%	53.0
	12206898	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	54.0	CHEMBL5940	Homo sapiens	Residual Activity	%	54.0
	12206899	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	0.0	CHEMBL5940	Homo sapiens	Residual Activity	%	0.0
	12206900	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	43.0	CHEMBL5940	Homo sapiens	Residual Activity	%	43.0
	12206901	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	88.0	CHEMBL5940	Homo sapiens	Residual Activity	%	88.0
	12206902	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	95.0	CHEMBL5940	Homo sapiens	Residual Activity	%	95.0
	12206903	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	95.0	CHEMBL5940	Homo sapiens	Residual Activity	%	95.0
	12206904	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	87.0	CHEMBL5940	Homo sapiens	Residual Activity	%	87.0
	12206905	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	44.0	CHEMBL5940	Homo sapiens	Residual Activity	%	44.0
	12206906	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	85.0	CHEMBL5940	Homo sapiens	Residual Activity	%	85.0
	12206907	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	35.0	CHEMBL5940	Homo sapiens	Residual Activity	%	35.0
	12206908	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	0.0	CHEMBL5940	Homo sapiens	Residual Activity	%	0.0
	12206909	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	75.0	CHEMBL5940	Homo sapiens	Residual Activity	%	75.0
	12206910	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	83.0	CHEMBL5940	Homo sapiens	Residual Activity	%	83.0
	12206911	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	98.0	CHEMBL5940	Homo sapiens	Residual Activity	%	98.0
	12206912	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	49.0	CHEMBL5940	Homo sapiens	Residual Activity	%	49.0
	12206913	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	82.0	CHEMBL5940	Homo sapiens	Residual Activity	%	82.0
	12206914	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	89.0	CHEMBL5940	Homo sapiens	Residual Activity	%	89.0
	12206915	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	71.0	CHEMBL5940	Homo sapiens	Residual Activity	%	71.0
	12206916	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	81.0	CHEMBL5940	Homo sapiens	Residual Activity	%	81.0
	12206917	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	90.0	CHEMBL5940	Homo sapiens	Residual Activity	%	90.0
	12206918	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	50.0	CHEMBL5940	Homo sapiens	Residual Activity	%	50.0
	12206919	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	25.0	CHEMBL5940	Homo sapiens	Residual Activity	%	25.0
	12206920	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	94.0	CHEMBL5940	Homo sapiens	Residual Activity	%	94.0
	12206921	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	36.0	CHEMBL5940	Homo sapiens	Residual Activity	%	36.0
	12206922	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	20.0	CHEMBL5940	Homo sapiens	Residual Activity	%	20.0
	12206923	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	76.0	CHEMBL5940	Homo sapiens	Residual Activity	%	76.0
	12206924	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	3.0	CHEMBL5940	Homo sapiens	Residual Activity	%	3.0
	12206925	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	80.0	CHEMBL5940	Homo sapiens	Residual Activity	%	80.0
	12206926	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL5940	Homo sapiens	Residual Activity	%	1.0
	12206927	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	98.0	CHEMBL5940	Homo sapiens	Residual Activity	%	98.0
	12206928	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	8.0	CHEMBL5940	Homo sapiens	Residual Activity	%	8.0
	12206929	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	34.0	CHEMBL5940	Homo sapiens	Residual Activity	%	34.0
	12206930	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	86.0	CHEMBL5940	Homo sapiens	Residual Activity	%	86.0
	12206931	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	17.0	CHEMBL5940	Homo sapiens	Residual Activity	%	17.0
	12206932	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	94.0	CHEMBL5940	Homo sapiens	Residual Activity	%	94.0
	12206933	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	76.0	CHEMBL5940	Homo sapiens	Residual Activity	%	76.0
	12206934	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	108.0	CHEMBL5940	Homo sapiens	Residual Activity	%	108.0
	12206935	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	96.0	CHEMBL5940	Homo sapiens	Residual Activity	%	96.0
	12206936	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	5.0	CHEMBL5940	Homo sapiens	Residual Activity	%	5.0
	12206937	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	74.0	CHEMBL5940	Homo sapiens	Residual Activity	%	74.0
	12206938	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	78.0	CHEMBL5940	Homo sapiens	Residual Activity	%	78.0
	12206939	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	26.0	CHEMBL5940	Homo sapiens	Residual Activity	%	26.0
	12206940	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	92.0	CHEMBL5940	Homo sapiens	Residual Activity	%	92.0
	12206941	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	92.0	CHEMBL5940	Homo sapiens	Residual Activity	%	92.0
	12206942	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	90.0	CHEMBL5940	Homo sapiens	Residual Activity	%	90.0
	12206943	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	80.0	CHEMBL5940	Homo sapiens	Residual Activity	%	80.0
	12206944	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	89.0	CHEMBL5940	Homo sapiens	Residual Activity	%	89.0
	12206945	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	80.0	CHEMBL5940	Homo sapiens	Residual Activity	%	80.0
	12206946	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	76.0	CHEMBL5940	Homo sapiens	Residual Activity	%	76.0
	12206947	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	21.0	CHEMBL5940	Homo sapiens	Residual Activity	%	21.0
	12206948	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL5940	Homo sapiens	Residual Activity	%	0.0
	12206949	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	85.0	CHEMBL5940	Homo sapiens	Residual Activity	%	85.0
	12206950	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	29.0	CHEMBL5940	Homo sapiens	Residual Activity	%	29.0
	12206951	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	28.0	CHEMBL5940	Homo sapiens	Residual Activity	%	28.0
	12206952	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	81.0	CHEMBL5940	Homo sapiens	Residual Activity	%	81.0
	12206953	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	65.0	CHEMBL5940	Homo sapiens	Residual Activity	%	65.0
	12206954	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	77.0	CHEMBL5940	Homo sapiens	Residual Activity	%	77.0
	12206955	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	83.0	CHEMBL5940	Homo sapiens	Residual Activity	%	83.0
	12206956	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	12.0	CHEMBL5940	Homo sapiens	Residual Activity	%	12.0
	12206957	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	90.0	CHEMBL5940	Homo sapiens	Residual Activity	%	90.0
	12209790	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	89.0	CHEMBL5940	Homo sapiens	Residual Activity	%	89.0
	12209791	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	9.0	CHEMBL5940	Homo sapiens	Residual Activity	%	9.0
	12209792	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	74.0	CHEMBL5940	Homo sapiens	Residual Activity	%	74.0
	12209793	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	70.0	CHEMBL5940	Homo sapiens	Residual Activity	%	70.0
	12209794	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	70.0	CHEMBL5940	Homo sapiens	Residual Activity	%	70.0
	12209795	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	17.0	CHEMBL5940	Homo sapiens	Residual Activity	%	17.0
	12209796	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	77.0	CHEMBL5940	Homo sapiens	Residual Activity	%	77.0
	12209797	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	83.0	CHEMBL5940	Homo sapiens	Residual Activity	%	83.0
	12209798	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	97.0	CHEMBL5940	Homo sapiens	Residual Activity	%	97.0
	12209799	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	38.0	CHEMBL5940	Homo sapiens	Residual Activity	%	38.0
	12209800	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	35.0	CHEMBL5940	Homo sapiens	Residual Activity	%	35.0
	12209801	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	26.0	CHEMBL5940	Homo sapiens	Residual Activity	%	26.0
	12209802	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	5.0	CHEMBL5940	Homo sapiens	Residual Activity	%	5.0
	12209803	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	8.0	CHEMBL5940	Homo sapiens	Residual Activity	%	8.0
	12209804	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	78.0	CHEMBL5940	Homo sapiens	Residual Activity	%	78.0
	12209805	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	46.0	CHEMBL5940	Homo sapiens	Residual Activity	%	46.0
	12209806	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	93.0	CHEMBL5940	Homo sapiens	Residual Activity	%	93.0
	12209807	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	76.0	CHEMBL5940	Homo sapiens	Residual Activity	%	76.0
	12209808	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL5940	Homo sapiens	Residual Activity	%	0.0
	12209809	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	72.0	CHEMBL5940	Homo sapiens	Residual Activity	%	72.0
	12209810	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	76.0	CHEMBL5940	Homo sapiens	Residual Activity	%	76.0
	12209811	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	6.0	CHEMBL5940	Homo sapiens	Residual Activity	%	6.0
	12209812	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	81.0	CHEMBL5940	Homo sapiens	Residual Activity	%	81.0
	12209813	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	11.0	CHEMBL5940	Homo sapiens	Residual Activity	%	11.0
	12209814	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	38.0	CHEMBL5940	Homo sapiens	Residual Activity	%	38.0
	12209815	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	74.0	CHEMBL5940	Homo sapiens	Residual Activity	%	74.0
	12209816	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	17.0	CHEMBL5940	Homo sapiens	Residual Activity	%	17.0
	12209817	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	19.0	CHEMBL5940	Homo sapiens	Residual Activity	%	19.0
	12209818	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	62.0	CHEMBL5940	Homo sapiens	Residual Activity	%	62.0
	12209819	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	54.0	CHEMBL5940	Homo sapiens	Residual Activity	%	54.0
	12209820	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	37.0	CHEMBL5940	Homo sapiens	Residual Activity	%	37.0
	12209821	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	35.0	CHEMBL5940	Homo sapiens	Residual Activity	%	35.0
	12209822	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	16.0	CHEMBL5940	Homo sapiens	Residual Activity	%	16.0
	12209823	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	89.0	CHEMBL5940	Homo sapiens	Residual Activity	%	89.0
	12209824	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	47.0	CHEMBL5940	Homo sapiens	Residual Activity	%	47.0
	12209825	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	39.0	CHEMBL5940	Homo sapiens	Residual Activity	%	39.0
	12209826	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	48.0	CHEMBL5940	Homo sapiens	Residual Activity	%	48.0
	12209827	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	69.0	CHEMBL5940	Homo sapiens	Residual Activity	%	69.0
	12209828	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	85.0	CHEMBL5940	Homo sapiens	Residual Activity	%	85.0
	12209829	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	4.0	CHEMBL5940	Homo sapiens	Residual Activity	%	4.0
	12209830	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	82.0	CHEMBL5940	Homo sapiens	Residual Activity	%	82.0
	12209831	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	85.0	CHEMBL5940	Homo sapiens	Residual Activity	%	85.0
	12209832	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	79.0	CHEMBL5940	Homo sapiens	Residual Activity	%	79.0
	12209833	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	92.0	CHEMBL5940	Homo sapiens	Residual Activity	%	92.0
	12209834	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	62.0	CHEMBL5940	Homo sapiens	Residual Activity	%	62.0
	12209835	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	97.0	CHEMBL5940	Homo sapiens	Residual Activity	%	97.0
	12209836	CHEMBL2219260	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	-1.0	CHEMBL5940	Homo sapiens	Residual Activity	%	-1.0
	12252065	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	105.0	CHEMBL5940	Homo sapiens	Residual Activity	%	105.0
	12252066	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	81.0	CHEMBL5940	Homo sapiens	Residual Activity	%	81.0
	12252067	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	83.0	CHEMBL5940	Homo sapiens	Residual Activity	%	83.0
	12252068	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	86.0	CHEMBL5940	Homo sapiens	Residual Activity	%	86.0
	12252069	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	88.0	CHEMBL5940	Homo sapiens	Residual Activity	%	88.0
	12252070	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	89.0	CHEMBL5940	Homo sapiens	Residual Activity	%	89.0
	12252071	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	23.0	CHEMBL5940	Homo sapiens	Residual Activity	%	23.0
	12252072	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	94.0	CHEMBL5940	Homo sapiens	Residual Activity	%	94.0
	12252073	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	107.0	CHEMBL5940	Homo sapiens	Residual Activity	%	107.0
	12252074	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	102.0	CHEMBL5940	Homo sapiens	Residual Activity	%	102.0
	12252075	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	87.0	CHEMBL5940	Homo sapiens	Residual Activity	%	87.0
	12252076	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	80.0	CHEMBL5940	Homo sapiens	Residual Activity	%	80.0
	12252077	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	84.0	CHEMBL5940	Homo sapiens	Residual Activity	%	84.0
	12252078	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	91.0	CHEMBL5940	Homo sapiens	Residual Activity	%	91.0
	12252079	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	72.0	CHEMBL5940	Homo sapiens	Residual Activity	%	72.0
	12252080	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	89.0	CHEMBL5940	Homo sapiens	Residual Activity	%	89.0
	12252081	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	108.0	CHEMBL5940	Homo sapiens	Residual Activity	%	108.0
	12252082	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	98.0	CHEMBL5940	Homo sapiens	Residual Activity	%	98.0
	12252083	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	81.0	CHEMBL5940	Homo sapiens	Residual Activity	%	81.0
	12252084	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	29.0	CHEMBL5940	Homo sapiens	Residual Activity	%	29.0
	12252085	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	80.0	CHEMBL5940	Homo sapiens	Residual Activity	%	80.0
	12252086	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	82.0	CHEMBL5940	Homo sapiens	Residual Activity	%	82.0
	12252087	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	91.0	CHEMBL5940	Homo sapiens	Residual Activity	%	91.0
	12252088	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	93.0	CHEMBL5940	Homo sapiens	Residual Activity	%	93.0
	12252089	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	96.0	CHEMBL5940	Homo sapiens	Residual Activity	%	96.0
	12252090	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	82.0	CHEMBL5940	Homo sapiens	Residual Activity	%	82.0
	12252091	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	40.0	CHEMBL5940	Homo sapiens	Residual Activity	%	40.0
	12252092	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	70.0	CHEMBL5940	Homo sapiens	Residual Activity	%	70.0
	12252093	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	86.0	CHEMBL5940	Homo sapiens	Residual Activity	%	86.0
	12252094	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	77.0	CHEMBL5940	Homo sapiens	Residual Activity	%	77.0
	12252095	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	93.0	CHEMBL5940	Homo sapiens	Residual Activity	%	93.0
	12252096	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	99.0	CHEMBL5940	Homo sapiens	Residual Activity	%	99.0
	12252097	CHEMBL2219259	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	99.0	CHEMBL5940	Homo sapiens	Residual Activity	%	99.0
	12631637	CHEMBL2319697	Inhibition of MARK1 (unknown origin) in presence of ATP	B	Cc1cc(-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)on1		CHEMBL2312654	=	IC50	nM	1490.0	CHEMBL5940	Homo sapiens	IC50	uM	1.49
	12631638	CHEMBL2319697	Inhibition of MARK1 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]2COC[C@H]2O)CC1		CHEMBL2312652	=	IC50	nM	30000.0	CHEMBL5940	Homo sapiens	IC50	uM	30.0
	12631639	CHEMBL2319697	Inhibition of MARK1 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)CC1		CHEMBL2312649	=	IC50	nM	30000.0	CHEMBL5940	Homo sapiens	IC50	uM	30.0
Not Determined	12631640	CHEMBL2319697	Inhibition of MARK1 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC2CCCC2)CC1		CHEMBL2312646		IC50			CHEMBL5940	Homo sapiens	IC50		
Not Determined	12631641	CHEMBL2319697	Inhibition of MARK1 (unknown origin) in presence of ATP	B	COc1ccccc1CNc1ncc(C(=O)NC2CCN(C)CC2)c(NC2CCCC2)n1		CHEMBL2312645		IC50			CHEMBL5940	Homo sapiens	IC50		
	12647919	CHEMBL2329072	Inhibition of MARK1 (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	67.0	CHEMBL5940	Homo sapiens	INH	%	67.0
	12647920	CHEMBL2329072	Inhibition of MARK1 (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	77.0	CHEMBL5940	Homo sapiens	INH	%	77.0
	12647921	CHEMBL2329072	Inhibition of MARK1 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	20.0	CHEMBL5940	Homo sapiens	INH	%	20.0
	12647922	CHEMBL2329072	Inhibition of MARK1 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	87.0	CHEMBL5940	Homo sapiens	INH	%	87.0
	12649600	CHEMBL2329533	Inhibition of MARK1 (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	96.0	CHEMBL5940	Homo sapiens	INH	%	96.0
	12649601	CHEMBL2329533	Inhibition of MARK1 (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	98.0	CHEMBL5940	Homo sapiens	INH	%	98.0
	12649602	CHEMBL2329533	Inhibition of MARK1 (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	93.0	CHEMBL5940	Homo sapiens	INH	%	93.0
	12672995	CHEMBL2339725	Inhibition of recombinant MARK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	39.0	CHEMBL5940	Homo sapiens	Activity	%	39.0
	12672996	CHEMBL2339725	Inhibition of recombinant MARK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	31.0	CHEMBL5940	Homo sapiens	Activity	%	31.0
	12679737	CHEMBL2345848	Inhibition of MARK1 (unknown origin) at 1 uM	B	Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1		CHEMBL2331664	=	Inhibition	%	-1.0	CHEMBL5940	Homo sapiens	INH	%	-1.0
	12693213	CHEMBL2343897	Inhibition of MARK1 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL5940	Homo sapiens	IC50	nM	10000.0
	12727738	CHEMBL2351172	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	88.0	CHEMBL5940	Homo sapiens	Activity	%	88.0
	12729026	CHEMBL2351932	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL5940	Homo sapiens	Activity	%	96.0
	12729910	CHEMBL2349813	Inhibition of MARK1 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	94.0	CHEMBL5940	Homo sapiens	Activity	%	94.0
	12730169	CHEMBL2351172	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	97.0	CHEMBL5940	Homo sapiens	Activity	%	97.0
	13281359	CHEMBL2378434	Inhibition of MARK1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	65.0	CHEMBL5940	Homo sapiens	INH	%	65.0
	13281360	CHEMBL2378434	Inhibition of MARK1 (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	65.0	CHEMBL5940	Homo sapiens	INH	%	65.0
	13281361	CHEMBL2378434	Inhibition of MARK1 (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	70.0	CHEMBL5940	Homo sapiens	INH	%	70.0
	13281362	CHEMBL2378434	Inhibition of MARK1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	21.0	CHEMBL5940	Homo sapiens	INH	%	21.0
	13281363	CHEMBL2378434	Inhibition of MARK1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1	Outside typical range	CHEMBL2376144	=	Inhibition	%	-11.0	CHEMBL5940	Homo sapiens	INH	%	-11.0
	13281364	CHEMBL2378434	Inhibition of MARK1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	94.0	CHEMBL5940	Homo sapiens	INH	%	94.0
Not Active	13328762	CHEMBL2388485	Inhibition of MARK1 (unknown origin)	B	Cc1cccc2nc(Cn3cnc4ccccc43)cc(=O)n12		CHEMBL2386917		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
	13375785	CHEMBL2404181	Inhibition of MARK1 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	6.0	CHEMBL5940	Homo sapiens	INH	%	6.0
	13419682	CHEMBL2422100	Inhibition of MARK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	0.0	CHEMBL5940	Homo sapiens	INH	%	0.0
	13419683	CHEMBL2422100	Inhibition of MARK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	99.0	CHEMBL5940	Homo sapiens	INH	%	99.0
	13419684	CHEMBL2422100	Inhibition of MARK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	89.0	CHEMBL5940	Homo sapiens	INH	%	89.0
	13439820	CHEMBL2426965	Competitive binding affinity to MARK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	13442629	CHEMBL2426965	Competitive binding affinity to MARK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	66.0	CHEMBL5940	Homo sapiens	INH	%	66.0
	13445653	CHEMBL2426965	Competitive binding affinity to MARK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	13451640	CHEMBL2426965	Competitive binding affinity to MARK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	13476397	CHEMBL2439117	Inhibition of human wild type MARK1 at 1 uM by qPCR analysis relative to control	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	=	Inhibition	%	92.0	CHEMBL5940	Homo sapiens	INH	%	92.0
	13872102	CHEMBL3101411	Inhibition of human MARK1 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	107.0	CHEMBL5940	Homo sapiens	Activity	%	107.0
	13954764	CHEMBL3132492	Inhibition of human MARK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	61.0	CHEMBL5940	Homo sapiens	Activity	%	61.0
	13954767	CHEMBL3132492	Inhibition of human MARK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	58.0	CHEMBL5940	Homo sapiens	Activity	%	58.0
	13954772	CHEMBL3132492	Inhibition of human MARK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	48.0	CHEMBL5940	Homo sapiens	Activity	%	48.0
	13966035	CHEMBL3136650	Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	93.5	CHEMBL5940	Homo sapiens	INH	%	93.5
	13973310	CHEMBL3134907	Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL5940	Homo sapiens	INH	%	0.0
	13974028	CHEMBL3136492	Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	5.0	CHEMBL5940	Homo sapiens	INH	%	5.0
	13974119	CHEMBL3135765	Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	2.0	CHEMBL5940	Homo sapiens	INH	%	2.0
	13974210	CHEMBL3135283	Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	40.5	CHEMBL5940	Homo sapiens	INH	%	40.5
	13974301	CHEMBL3136853	Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	4.5	CHEMBL5940	Homo sapiens	INH	%	4.5
	13975039	CHEMBL3136117	Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL5940	Homo sapiens	INH	%	0.0
	13975130	CHEMBL3135726	Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	4.5	CHEMBL5940	Homo sapiens	INH	%	4.5
	13975221	CHEMBL3136379	Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	34.5	CHEMBL5940	Homo sapiens	INH	%	34.5
	13975864	CHEMBL3135479	Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	74.0	CHEMBL5940	Homo sapiens	INH	%	74.0
	13975957	CHEMBL3137011	Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	51.0	CHEMBL5940	Homo sapiens	INH	%	51.0
	13976048	CHEMBL3135404	Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	97.0	CHEMBL5940	Homo sapiens	INH	%	97.0
	13976139	CHEMBL3135076	Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	52.0	CHEMBL5940	Homo sapiens	INH	%	52.0
	14582546	CHEMBL3242547	Inhibition of human MARK1 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	117.0	CHEMBL5940	Homo sapiens	Activity	%	117.0
	14593768	CHEMBL3241184	Inhibition of human MARK1	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	>	IC50	nM	10000.0	CHEMBL5940	Homo sapiens	IC50	uM	10.0
	14658598	CHEMBL3265759	Inhibition of MARK1 kinase (unknown origin) at 1 uM	B	Nc1ncnc2ccc(-c3ccnc(F)c3)nc12		CHEMBL3262590	=	Inhibition	%	54.0	CHEMBL5940	Homo sapiens	INH	%	54.0
	14664227	CHEMBL3270891	Inhibition of MARK1 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	100.0	CHEMBL5940	Homo sapiens	INH	%	100.0
	14664228	CHEMBL3270891	Inhibition of MARK1 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	100.0	CHEMBL5940	Homo sapiens	INH	%	100.0
	14664229	CHEMBL3270891	Inhibition of MARK1 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	100.0	CHEMBL5940	Homo sapiens	INH	%	100.0
	14983183	CHEMBL3385016	Inhibition of MARK1 (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	90.0	CHEMBL5940	Homo sapiens	INH	%	90.0
	14984425	CHEMBL3384366	Inhibition of MARK1 (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	41.0	CHEMBL5940	Homo sapiens	INH	%	41.0
	15018633	CHEMBL3361525	Inhibition of MARK1 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	13.4	CHEMBL5940	Homo sapiens	INH	%	13.4
	15019187	CHEMBL3364380	Inhibition of MARK1 (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	4.0	CHEMBL5940	Homo sapiens	INH	%	4.0
	15072446	CHEMBL3380128	Inhibition of MARK1 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	99.0	CHEMBL5940	Homo sapiens	Activity	%	99.0
	15075121	CHEMBL3376333	Inhibition of MARK1 (unknown origin) at 1 uM	B	CC(C)(O)Cn1cc(-c2ccc(-c3cc4c(Nc5ccncc5)ncnn4c3)cc2)cn1		CHEMBL3326802	=	Inhibition	%	84.0	CHEMBL5940	Homo sapiens	INH	%	84.0
	15091082	CHEMBL3381547	Inhibition of human recombinant MARK1 using Ulight-RRRSLLE substrate assessed as remaining enzyme activity at 1 uM after 30 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	86.0	CHEMBL5940	Homo sapiens	Activity	%	86.0
	15251828	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	35.0	CHEMBL5940	Homo sapiens	Activity	%	35.0
	15251969	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	71.0	CHEMBL5940	Homo sapiens	Activity	%	71.0
	15252071	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	89.0	CHEMBL5940	Homo sapiens	Activity	%	89.0
	15252716	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	99.0	CHEMBL5940	Homo sapiens	Activity	%	99.0
	15252818	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	87.0	CHEMBL5940	Homo sapiens	Activity	%	87.0
	15252920	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	96.0	CHEMBL5940	Homo sapiens	Activity	%	96.0
	15253594	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	84.0	CHEMBL5940	Homo sapiens	Activity	%	84.0
	15253696	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	96.0	CHEMBL5940	Homo sapiens	Activity	%	96.0
	15254362	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	91.0	CHEMBL5940	Homo sapiens	Activity	%	91.0
	15254464	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	75.0	CHEMBL5940	Homo sapiens	Activity	%	75.0
	15254566	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	91.0	CHEMBL5940	Homo sapiens	Activity	%	91.0
	15255256	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	81.0	CHEMBL5940	Homo sapiens	Activity	%	81.0
	15255359	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	72.0	CHEMBL5940	Homo sapiens	Activity	%	72.0
	15255461	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	89.0	CHEMBL5940	Homo sapiens	Activity	%	89.0
	15256193	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	87.0	CHEMBL5940	Homo sapiens	Activity	%	87.0
	15256295	CHEMBL3428392	Inhibition of MARK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	80.0	CHEMBL5940	Homo sapiens	Activity	%	80.0
	15756926	CHEMBL3631284	Inhibition of MARK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	4.99	CHEMBL5940	Homo sapiens	INH	%	4.99
	15757797	CHEMBL3631284	Inhibition of MARK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	10.33	CHEMBL5940	Homo sapiens	INH	%	10.33
	15758776	CHEMBL3631284	Inhibition of MARK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	3.28	CHEMBL5940	Homo sapiens	INH	%	3.28
	16376461	CHEMBL3734485	Inhibition of recombinant human MARK1 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	0.0	CHEMBL5940	Homo sapiens	INH	%	0.0
	16388316	CHEMBL3737491	Inhibition of MARK1 (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	Inhibition	%	27.0	CHEMBL5940	Homo sapiens	INH	%	27.0
	16425246	CHEMBL3751277	Inhibition of MARK1 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-4.7	CHEMBL5940	Homo sapiens	INH	%	-4.7
	16431892	CHEMBL3747985	Inhibition of human MARK1 using [KKKVSRSGLYRSPSMPENLNRPR] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5940	Homo sapiens	IC50	uM	10.0
	16451503	CHEMBL3760626	Inhibition of MARK1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-1.8	CHEMBL5940	Homo sapiens	INH	%	-1.8
	16495124	CHEMBL3776242	Inhibition of N-terminal His6-tagged recombinant human MARK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-18.0	CHEMBL5940	Homo sapiens	Activity	%	-18.0
	16496043	CHEMBL3776242	Inhibition of N-terminal His6-tagged recombinant human MARK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-7.0	CHEMBL5940	Homo sapiens	Activity	%	-7.0
	16508230	CHEMBL3776242	Inhibition of N-terminal His6-tagged recombinant human MARK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	0.0	CHEMBL5940	Homo sapiens	Activity	%	0.0
	16578394	CHEMBL3802266	Inhibition of partial length wild type human MARK1 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	100.0	CHEMBL5940	Homo sapiens	Activity	%	100.0
	16611975	CHEMBL3815439	Inhibition of human MARK1 (2 to 795 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-26.0	CHEMBL5940	Homo sapiens	Activity	%	-26.0
	16614529	CHEMBL3816727	Inhibition of human MARK1 at 1 uM using [KKKVSRSGLYRSPSMPENLNRPR] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	8.0	CHEMBL5940	Homo sapiens	INH	%	8.0
	16618169	CHEMBL3817262	Inhibition of full length recombinant human GST-tagged MARK1 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	16619684	CHEMBL3820252	Inhibition of recombinant human full length GST-tagged MARK1 expressed in Baculovirus at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL5940	Homo sapiens	INH	%	75.0
	16642008	CHEMBL3826419	Inhibition of GST-tagged full-length recombinant human MARK1 expressed in baculovirus system at 100 nM by Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	17.0	CHEMBL5940	Homo sapiens	INH	%	17.0
	16654140	CHEMBL3829183	Inhibition of human MARK1 (2 to 795 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	67.0	CHEMBL5940	Homo sapiens	Activity	%	67.0
412033	17776748	CHEMBL3888676	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL5940	Homo sapiens	IC50	nM	10000.0
	18099876	CHEMBL4021783	Inhibition of MARK1 (unknown origin)	B	Cc1ccc(CNc2nc(N)nc3[nH]c4cc(C)c(O)cc4c23)cc1		CHEMBL4098682	>	IC50	nM	100000.0	CHEMBL5940	Homo sapiens	IC50	uM	100.0
	18114266	CHEMBL4025228	Inhibition of wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	88.0	CHEMBL5940	Homo sapiens	Activity	%	88.0
	18153280	CHEMBL4034390	Inhibition of MARK1 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	13.8	CHEMBL5940	Homo sapiens	INH	%	13.8
	18203752	CHEMBL4044039	Inhibition of wild-type human partial length MARK1 (Q30 to T341 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	99.0	CHEMBL5940	Homo sapiens	Activity	%	99.0
	18211566	CHEMBL4045750	Inhibition of MARK1 conserved Lys1 (EVAVKIIDK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-34.1	CHEMBL5940	Homo sapiens	INH	%	-34.1
	18211895	CHEMBL4045991	Inhibition of MARK1 conserved Lys1 (EVAVKIIDK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-33.1	CHEMBL5940	Homo sapiens	INH	%	-33.1
	18212138	CHEMBL4046156	Inhibition of MARK1 (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL5940	Homo sapiens	INH	%	20.0
	18218995	CHEMBL4047250	Inhibition of MARK1 (unknown origin) assessed as residual activity relative to control	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3ccccc3)ncc2C(N)=O)c1		CHEMBL4065693	<=	Activity	%	10.0	CHEMBL5940	Homo sapiens	Activity	%	10.0
	18232173	CHEMBL4050333	Inhibition of human MARK1 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	79.0	CHEMBL5940	Homo sapiens	Activity	%	79.0
	18253711	CHEMBL4055140	Inhibition of wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	99.0	CHEMBL5940	Homo sapiens	Activity	%	99.0
	18253712	CHEMBL4055140	Inhibition of wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	91.0	CHEMBL5940	Homo sapiens	Activity	%	91.0
	18265897	CHEMBL4057347	Inhibition of MARK1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	36.7	CHEMBL5940	Homo sapiens	INH	%	36.7
	18266091	CHEMBL4057541	Inhibition of MARK1 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	3.3	CHEMBL5940	Homo sapiens	INH	%	3.3
	18266187	CHEMBL4057637	Inhibition of MARK1 (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	3.3	CHEMBL5940	Homo sapiens	INH	%	3.3
	18275064	CHEMBL4118400	Inhibition of MARK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled EVAVKIIDK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	-5.7	CHEMBL5940	Homo sapiens	INH	%	-5.7
	18275065	CHEMBL4118400	Inhibition of MARK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled EVAVKIIDK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-11.1	CHEMBL5940	Homo sapiens	INH	%	-11.1
	18275066	CHEMBL4118400	Inhibition of MARK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled EVAVKIIDK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-23.4	CHEMBL5940	Homo sapiens	INH	%	-23.4
	18282163	CHEMBL4120118	Inhibition of recombinant full Length GST-tagged human MARK1 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	11.4	CHEMBL5940	Homo sapiens	INH	%	11.4
	18282482	CHEMBL4120118	Inhibition of recombinant full Length GST-tagged human MARK1 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	12.1	CHEMBL5940	Homo sapiens	INH	%	12.1
	18282725	CHEMBL4120310	Inhibition of MARK1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	36.7	CHEMBL5940	Homo sapiens	INH	%	36.7
	18282952	CHEMBL4120537	Inhibition of MARK1 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-5.3	CHEMBL5940	Homo sapiens	INH	%	-5.3
	18283176	CHEMBL4120761	Inhibition of MARK1 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12	Outside typical range	CHEMBL4129737	=	Inhibition	%	-16.0	CHEMBL5940	Homo sapiens	INH	%	-16.0
	18440294	CHEMBL4157118	Binding affinity to wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	96.0	CHEMBL5940	Homo sapiens	Activity	%	96.0
	18449914	CHEMBL4178150	Inhibition of human MARK1 (2 to 795 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	91.0	CHEMBL5940	Homo sapiens	Activity	%	91.0
	18463767	CHEMBL4181183	Inhibition of recombinant human N-terminal His6-tagged MARK1 (2 to end residues) expressed in baculovirus Sf21 cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	-1.0	CHEMBL5940	Homo sapiens	INH	%	-1.0
	18484250	CHEMBL4185897	Binding affinity to wild-type human partial length MARK1 (Q30 to T341 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	84.0	CHEMBL5940	Homo sapiens	Activity	%	84.0
	18484734	CHEMBL4185897	Binding affinity to wild-type human partial length MARK1 (Q30 to T341 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	85.0	CHEMBL5940	Homo sapiens	Activity	%	85.0
	18507721	CHEMBL4191041	Inhibition of recombinant human MARK1 (2 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-7.0	CHEMBL5940	Homo sapiens	INH	%	-7.0
	18653533	CHEMBL4230137	Inhibition of MARK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	1.0	CHEMBL5940	Homo sapiens	INH	%	1.0
	18653534	CHEMBL4230137	Inhibition of MARK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	-2.0	CHEMBL5940	Homo sapiens	INH	%	-2.0
	18655438	CHEMBL4230797	Binding affinity to wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	97.0	CHEMBL5940	Homo sapiens	Activity	%	97.0
	18665395	CHEMBL4233352	Inhibition of MARK1 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL5940	Homo sapiens	IC50	nM	1000.0
	18674746	CHEMBL4235383	Inhibition of MARK1 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL5940	Homo sapiens	Ki	nM	2000.0
	18674747	CHEMBL4235383	Inhibition of MARK1 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL5940	Homo sapiens	Ki	nM	2000.0
Not Determined	18674748	CHEMBL4235383	Inhibition of MARK1 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL5940	Homo sapiens	Ki		
	18694005	CHEMBL4253458	Inhibition of recombinant human full length GST-tagged MARK1 expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	3.0	CHEMBL5940	Homo sapiens	INH	%	3.0
	18694087	CHEMBL4253540	Inhibition of recombinant human full length GST-tagged MARK1 expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	16.0	CHEMBL5940	Homo sapiens	INH	%	16.0
	18702485	CHEMBL4255122	Inhibition of recombinant human full length GST-tagged MARK1 expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	Inhibition	%	0.0	CHEMBL5940	Homo sapiens	INH	%	0.0
	18702554	CHEMBL4255122	Inhibition of recombinant human full length GST-tagged MARK1 expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	Inhibition	%	0.0	CHEMBL5940	Homo sapiens	INH	%	0.0
	18702598	CHEMBL4255122	Inhibition of recombinant human full length GST-tagged MARK1 expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	Inhibition	%	3.0	CHEMBL5940	Homo sapiens	INH	%	3.0
	18702650	CHEMBL4255122	Inhibition of recombinant human full length GST-tagged MARK1 expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Inhibition	%	-1.0	CHEMBL5940	Homo sapiens	INH	%	-1.0
	18702694	CHEMBL4255122	Inhibition of recombinant human full length GST-tagged MARK1 expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Inhibition	%	5.0	CHEMBL5940	Homo sapiens	INH	%	5.0
	18702737	CHEMBL4255122	Inhibition of recombinant human full length GST-tagged MARK1 expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Inhibition	%	-1.0	CHEMBL5940	Homo sapiens	INH	%	-1.0
	18751037	CHEMBL4263855	Inhibition of MARK1 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	14.0	CHEMBL5940	Homo sapiens	INH	%	14.0
	18752011	CHEMBL4264386	Binding affinity to wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	91.0	CHEMBL5940	Homo sapiens	Activity	%	91.0
	18761534	CHEMBL4266587	Inhibition of recombinant human N-terminal His6-tagged MARK1 (2 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	18.0	CHEMBL5940	Homo sapiens	INH	%	18.0
	18761805	CHEMBL4266587	Inhibition of recombinant human N-terminal His6-tagged MARK1 (2 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	10.0	CHEMBL5940	Homo sapiens	INH	%	10.0
	18761968	CHEMBL4266587	Inhibition of recombinant human N-terminal His6-tagged MARK1 (2 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-3.0	CHEMBL5940	Homo sapiens	INH	%	-3.0
	18858050	CHEMBL4307896	Binding affinity to wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	67.0	CHEMBL5940	Homo sapiens	Activity	%	67.0
	18919563	CHEMBL4322919	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged MARK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	9.0	CHEMBL5940	Homo sapiens	Kd	nM	9.0
	18919751	CHEMBL4322919	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged MARK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	3.0	CHEMBL5940	Homo sapiens	Kd	nM	3.0
	18938057	CHEMBL4327755	Inhibition of human MARK1 assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	100.11	CHEMBL5940	Homo sapiens	Activity	%	100.11
	18938058	CHEMBL4327755	Inhibition of human MARK1 assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	97.25	CHEMBL5940	Homo sapiens	Activity	%	97.25
	18938600	CHEMBL4328119	Inhibition of human MARK1 assessed as residual activity at 100 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5940	Homo sapiens	Activity	%	65.0
	18938980	CHEMBL4328483	Inhibition of human MARK1 using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.417	CHEMBL5940	Homo sapiens	IC50	10'-10M	4.17
	18958961	CHEMBL4333483	Binding affinity to wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	67.0	CHEMBL5940	Homo sapiens	Activity	%	67.0
	19021528	CHEMBL4347750	Inhibition of recombinant human MARK1 at 20 nM using Ulight-RRRSLLE as substrate measured after 30 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	8.0	CHEMBL5940	Homo sapiens	INH	%	8.0
	19021529	CHEMBL4347751	Inhibition of recombinant human MARK1 at 200 nM using Ulight-RRRSLLE as substrate measured after 30 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	10.0	CHEMBL5940	Homo sapiens	INH	%	10.0
	19032200	CHEMBL4349793	Inhibition of recombinant human full length N-terminal GST/His6-tagged MARK1 (M1 to L780) expressed in Sf9 insect cells at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	-8.0	CHEMBL5940	Homo sapiens	INH	%	-8.0
Active	19041170	CHEMBL4352431	Inhibition of human MARK1 at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
	19059674	CHEMBL4357975	Binding affinity to wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	99.0	CHEMBL5940	Homo sapiens	Activity	%	99.0
	19090239	CHEMBL4365813	Inhibition of wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL5940	Homo sapiens	Activity	%	100.0
	19091992	CHEMBL4366466	Inhibition of human MARK1 at 100 nM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-14.45	CHEMBL5940	Homo sapiens	INH	%	-14.45
	19159502	CHEMBL4382606	Binding affinity to wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	40.0	CHEMBL5940	Homo sapiens	Activity	%	40.0
	19181075	CHEMBL4387286	Inhibition of recombinant full length human GST-tagged MARK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-21 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	6.0	CHEMBL5940	Homo sapiens	INH	%	6.0
	19181301	CHEMBL4387286	Inhibition of recombinant full length human GST-tagged MARK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-21 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	16.5	CHEMBL5940	Homo sapiens	INH	%	16.5
	19191505	CHEMBL4389325	Inhibition of wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	81.0	CHEMBL5940	Homo sapiens	INH	%	81.0
	19191988	CHEMBL4389802	Inhibition of wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	97.0	CHEMBL5940	Homo sapiens	INH	%	97.0
	19200244	CHEMBL4391428	Binding affinity to wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	50.0	CHEMBL5940	Homo sapiens	Activity	%	50.0
	19225476	CHEMBL4395896	Inhibition of human recombinant MARK1 at 1 uM using Ulight-RRRSLLE as substrate measured after 30 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	-5.3	CHEMBL5940	Homo sapiens	INH	%	-5.3
	19266489	CHEMBL4405439	Inhibition of wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5940	Homo sapiens	INH	%	50.0
	19276033	CHEMBL4408036	Inhibition of recombinant human MARK1 (2 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	74.0	CHEMBL5940	Homo sapiens	INH	%	74.0
Not Active	19296707	CHEMBL4412643	Inhibition of MARK1 (unknown origin) at 10 uM after 60 mins by ADP-Glo luminescence assay	B	COc1ccc(Cn2cc(C(=O)N/N=C3/C(=O)Nc4c(C)cccc43)nn2)cc1		CHEMBL4529234		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
Active	19342254	CHEMBL4419781	Binding affinity to human MARK1	B	CN1CC(=O)N2[C@@H](Cc3cc4c(cc3[C@H]2c2c[nH]c3ccc(Cl)cc23)OCO4)C1=O		CHEMBL4461905		Activity			CHEMBL5940	Homo sapiens	Activity		
	20600587	CHEMBL4603539	Inhibition of recombinant full length human GST-tagged MARK1 expressed in baculovirus expression system using serine/threonine-21 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL5940	Homo sapiens	IC50	uM	100.0
	22392095	CHEMBL4667190	Inhibition of recombinant human GST-tagged full length MARK1 expressed in baculovirus expression system using Ser/Thr 21 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	-5.5	CHEMBL5940	Homo sapiens	INH	%	-5.5
	22423487	CHEMBL4674319	Inhibition of human MARK1 using KKKVSRSGLYRSPSMPENLNRPR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	77.49	CHEMBL5940	Homo sapiens	Activity	%	77.49
	22423488	CHEMBL4674319	Inhibition of human MARK1 using KKKVSRSGLYRSPSMPENLNRPR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	4.96	CHEMBL5940	Homo sapiens	Activity	%	4.96
	22843684	CHEMBL4720670	Inhibition of human MARK1 using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.261	CHEMBL5940	Homo sapiens	IC50	10^-10M	2.61
	22844033	CHEMBL4721019	Inhibition of human MARK1 assessed as residual activity using KKKVSRSGLYRSPSMPENLNRPR as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	98.56	CHEMBL5940	Homo sapiens	Activity	%	98.56
	22844781	CHEMBL4721456	Inhibition of wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	98.49	CHEMBL5940	Homo sapiens	Activity	%	98.49
Not Active	22909943	CHEMBL4734075	Inhibition of recombinant human full length GST-tagged MARK1 expressed in baculovirus expression system using serine/threonine-21 peptide as substrate at 10 uM by Z'-LYTE assay	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
Not Active	22909944	CHEMBL4734075	Inhibition of recombinant human full length GST-tagged MARK1 expressed in baculovirus expression system using serine/threonine-21 peptide as substrate at 10 uM by Z'-LYTE assay	B	Clc1cccc(CSc2ncnc3[nH]cnc23)c1		CHEMBL4754930		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
Not Active	22909945	CHEMBL4734075	Inhibition of recombinant human full length GST-tagged MARK1 expressed in baculovirus expression system using serine/threonine-21 peptide as substrate at 10 uM by Z'-LYTE assay	B	Brc1ccccc1CSc1ncnc2[nH]cnc12		CHEMBL4776788		Inhibition	%		CHEMBL5940	Homo sapiens	INH		
	22952898	CHEMBL4766835	Inhibition of recombinant human MARK1 (2 to end residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	97.0	CHEMBL5940	Homo sapiens	Activity	%	97.0
	23120650	CHEMBL4804425	Inhibition of MARK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	2900.0	CHEMBL5940	Homo sapiens	IC50	uM	2.9
	23120651	CHEMBL4804425	Inhibition of MARK1 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-1300.0	CHEMBL5940	Homo sapiens	IC50	uM	-1.3
	23120652	CHEMBL4804425	Inhibition of MARK1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-29500.0	CHEMBL5940	Homo sapiens	IC50	uM	-29.5
	23120653	CHEMBL4804425	Inhibition of MARK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	9300.0	CHEMBL5940	Homo sapiens	IC50	uM	9.3
	23120654	CHEMBL4804425	Inhibition of MARK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-29400.0	CHEMBL5940	Homo sapiens	IC50	uM	-29.4
	23120655	CHEMBL4804425	Inhibition of MARK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	40700.0	CHEMBL5940	Homo sapiens	IC50	uM	40.7
	23121689	CHEMBL4804607	Inhibition of MARK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL5940	Homo sapiens	INH	%	0.0
	23121690	CHEMBL4804607	Inhibition of MARK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL5940	Homo sapiens	INH	%	0.0
	23121691	CHEMBL4804607	Inhibition of MARK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL5940	Homo sapiens	INH	%	0.0
	23121692	CHEMBL4804607	Inhibition of MARK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL5940	Homo sapiens	INH	%	0.0
	23121693	CHEMBL4804607	Inhibition of MARK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL5940	Homo sapiens	INH	%	0.0
	23121694	CHEMBL4804607	Inhibition of MARK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	35.0	CHEMBL5940	Homo sapiens	INH	%	35.0
	23122660	CHEMBL4805011	Inhibition of human MARK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	81.0	CHEMBL5940	Homo sapiens	Activity	%	81.0
	23123355	CHEMBL4805599	Inhibition of human MARK1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	92.0	CHEMBL5940	Homo sapiens	Activity	%	92.0
	23123814	CHEMBL4806058	Inhibition of DNA-tagged human MARK1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	92.0	CHEMBL5940	Homo sapiens	Activity	%	92.0
	23124800	CHEMBL4806616	Inhibition of human MARK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5940	Homo sapiens	Activity	%	100.0
	23124801	CHEMBL4806616	Inhibition of human MARK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5940	Homo sapiens	Activity	%	100.0
	23128272	CHEMBL4807899	Inhibition of MARK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5940	Homo sapiens	Activity	%	75.0
	23128273	CHEMBL4807899	Inhibition of MARK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5940	Homo sapiens	Activity	%	75.0
	23128274	CHEMBL4807899	Inhibition of MARK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5940	Homo sapiens	Activity	%	75.0
	23128922	CHEMBL4808098	Inhibition of MARK1 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)n(CCN(C)C)c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4847460	=	Inhibition	%	44.0	CHEMBL5940	Homo sapiens	INH	%	44.0
	23234020	CHEMBL4827599	Inhibition of wild-type human partial length MARK1 (Q30 to T341 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2cnn3ccccc23)cc1C1CCCC1		CHEMBL4851925	<	Activity	%	10.0	CHEMBL5940	Homo sapiens	Activity	%	10.0
	23299268	CHEMBL4841734	Inhibition of MARK1 (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	17.0	CHEMBL5940	Homo sapiens	INH	%	17.0
	23299269	CHEMBL4841734	Inhibition of MARK1 (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	57.0	CHEMBL5940	Homo sapiens	INH	%	57.0
Not Active	23317495	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23317963	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	99.0	CHEMBL5940	Homo sapiens	% Control	%	99.0
Not Active	23318630	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	57.0	CHEMBL5940	Homo sapiens	% Control	%	57.0
Not Active	23319113	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23319750	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	96.5	CHEMBL5940	Homo sapiens	% Control	%	96.5
Not Active	23320225	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	88.7	CHEMBL5940	Homo sapiens	% Control	%	88.7
Not Active	23320903	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23321371	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23322001	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23322469	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23323158	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23323626	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	79.0	CHEMBL5940	Homo sapiens	% Control	%	79.0
Not Active	23324053	CHEMBL4880672	MARK1 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	11.0	CHEMBL5940	Homo sapiens	% inhibition	%	11.0
Not Active	23324480	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	91.1	CHEMBL5940	Homo sapiens	% Control	%	91.1
Not Active	23325115	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	99.0	CHEMBL5940	Homo sapiens	% Control	%	99.0
Not Active	23325583	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23326230	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23326698	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	83.0	CHEMBL5940	Homo sapiens	% Control	%	83.0
Not Active	23327398	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23327866	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23328453	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23328921	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23329411	CHEMBL4881118	MARK1(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	112.0	CHEMBL5940	Homo sapiens	% residual kinase activity	%	112.0
Not Active	23329867	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23330335	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23331091	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23331559	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	91.0	CHEMBL5940	Homo sapiens	% Control	%	91.0
Not Active	23332146	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	96.7	CHEMBL5940	Homo sapiens	% Control	%	96.7
Not Active	23332612	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23333330	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23333969	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23334437	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23335416	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	82.0	CHEMBL5940	Homo sapiens	% Control	%	82.0
Not Active	23335884	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23336511	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	98.0	CHEMBL5940	Homo sapiens	% Control	%	98.0
Not Active	23336979	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	84.0	CHEMBL5940	Homo sapiens	% Control	%	84.0
Not Active	23337675	CHEMBL4882046	MARK1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	98.0	CHEMBL5940	Homo sapiens	% Ctrl	%	98.0
Not Active	23338060	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	92.0	CHEMBL5940	Homo sapiens	% Control	%	92.0
Not Active	23338528	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23339140	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23339608	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23340245	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23340713	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	92.0	CHEMBL5940	Homo sapiens	% Control	%	92.0
Not Active	23341370	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23341838	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23342454	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23342922	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	86.0	CHEMBL5940	Homo sapiens	% Control	%	86.0
Not Active	23343552	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	76.0	CHEMBL5940	Homo sapiens	% Control	%	76.0
Not Active	23344020	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23344658	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23345231	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23345699	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23346276	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	95.3	CHEMBL5940	Homo sapiens	% Control	%	95.3
Not Active	23346744	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	62.8	CHEMBL5940	Homo sapiens	% Control	%	62.8
Not Active	23347346	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	97.0	CHEMBL5940	Homo sapiens	% Control	%	97.0
Not Active	23347836	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	78.7	CHEMBL5940	Homo sapiens	% Control	%	78.7
Not Active	23348415	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23348883	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23349470	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23350088	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23350556	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	99.0	CHEMBL5940	Homo sapiens	% Control	%	99.0
Not Active	23351161	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23351629	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	89.0	CHEMBL5940	Homo sapiens	% Control	%	89.0
Not Active	23352127	CHEMBL4882816	MARK1 (MARK) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	8.353	CHEMBL5940	Homo sapiens	% Inhibition	%	8.3532
Not Active	23352653	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23353121	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23354003	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23354471	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23355203	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23355671	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	92.0	CHEMBL5940	Homo sapiens	% Control	%	92.0
Not Active	23356307	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23356775	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23357384	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23358031	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	84.0	CHEMBL5940	Homo sapiens	% Control	%	84.0
Not Active	23358499	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23359085	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	96.7	CHEMBL5940	Homo sapiens	% Control	%	96.7
Not Active	23359683	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	97.0	CHEMBL5940	Homo sapiens	% Control	%	97.0
Not Active	23360151	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23360736	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	92.0	CHEMBL5940	Homo sapiens	% Control	%	92.0
Not Active	23361204	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	76.0	CHEMBL5940	Homo sapiens	% Control	%	76.0
Not Active	23361777	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	74.0	CHEMBL5940	Homo sapiens	% Control	%	74.0
Not Active	23362313	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23362781	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	90.0	CHEMBL5940	Homo sapiens	% Control	%	90.0
Not Active	23364423	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	74.0	CHEMBL5940	Homo sapiens	% Control	%	74.0
Not Active	23364891	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	81.0	CHEMBL5940	Homo sapiens	% Control	%	81.0
Not Active	23365630	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	93.0	CHEMBL5940	Homo sapiens	% Control	%	93.0
Not Active	23366173	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23366763	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	79.0	CHEMBL5940	Homo sapiens	% Control	%	79.0
Not Active	23367231	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23367633	CHEMBL4883986	MARK1 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	88.0	CHEMBL5940	Homo sapiens	% Residual activity with Skepinone-L	%	88.0
Not Active	23368109	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	71.0	CHEMBL5940	Homo sapiens	% Control	%	71.0
Not Active	23368577	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	81.0	CHEMBL5940	Homo sapiens	% Control	%	81.0
Not Active	23369176	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23369644	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23370132	CHEMBL4884376	MARK1(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	66.0	CHEMBL5940	Homo sapiens	% residual kinase activity	%	66.0
Slightly Active	23370612	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	36.0	CHEMBL5940	Homo sapiens	% Control	%	36.0
Not Active	23371080	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23371889	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23372357	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	74.0	CHEMBL5940	Homo sapiens	% Control	%	74.0
	23372808	CHEMBL4884773	MARK1(MAR1PHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5940	Homo sapiens	pIC50		6.0
	23373217	CHEMBL4885064	MARK1(MAR1PHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5940	Homo sapiens	pIC50		6.0
	23373575	CHEMBL4885352	MARK1(MAR1PHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5940	Homo sapiens	pIC50		6.0
Not Active	23375028	CHEMBL4886017	MARK1 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	-1.0	CHEMBL5940	Homo sapiens	% Inhibition	%	-1.0
Not Active	23375287	CHEMBL4886269	MAP/microtubule affinity-regulating kinase 1 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-6.0	CHEMBL5940	Homo sapiens	% inhibition	%	-6.0
Not Active	23375784	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	99.0	CHEMBL5940	Homo sapiens	% Control	%	99.0
Not Active	23376252	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	90.0	CHEMBL5940	Homo sapiens	% Control	%	90.0
Not Active	23376829	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23377297	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	99.0	CHEMBL5940	Homo sapiens	% Control	%	99.0
Not Active	23378157	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	89.0	CHEMBL5940	Homo sapiens	% Control	%	89.0
Not Active	23378625	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23379792	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	94.0	CHEMBL5940	Homo sapiens	% Control	%	94.0
Not Active	23380260	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23380954	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23381602	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23382070	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23382416	CHEMBL4887132	MARK1 Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		Inhibition	%	81.0	CHEMBL5940	Homo sapiens	% inhibition	%	81.0
	23382417	CHEMBL4887132	MARK1 Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		IC50	nM	448.0	CHEMBL5940	Homo sapiens	IC50	nM	448.0
Not Active	23382694	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL5940	Homo sapiens	% Control	%	100.0
Not Active	23383162	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	77.0	CHEMBL5940	Homo sapiens	% Control	%	77.0
Not Active	23383881	CHEMBL4887500	MARK1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	91.0	CHEMBL5940	Homo sapiens	% Ctrl	%	91.0
Not Active	23384338	CHEMBL4887933	MARK1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	2.52	CHEMBL5940	Homo sapiens	% inhibition	%	2.52
Not Active	23384672	CHEMBL4888198	MARK1 (MARK) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	-7.0	CHEMBL5940	Homo sapiens	% Inhibition	%	-7.0
Not Active	23385077	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	69.0	CHEMBL5940	Homo sapiens	% Control	%	69.0
Not Active	23385544	CHEMBL4879801	KinomeScan assay: inhibition of MARK1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	81.0	CHEMBL5940	Homo sapiens	% Control	%	81.0
